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ABSTRACT 
Active  extrusion  of  Cl- from the neuronal cytoplasm by the neuron-specific K-Cl co-
transporter isoform KCC2 is necessary for the hyperpolarizing inhibitory Cl- currents 
mediated by the GABA receptors (GABAARs). Early in development and following 
cellular trauma or seizures, GABAAR-mediated signaling is often depolarizing and may 
even, in contrast to its classical inhibitory action, promote action potential firing. De-
velopmental up-regulation of KCC2 is largely responsible for the shift from depolariz-
ing to hyperpolarizing GABAAR-mediated signaling, and conditions associated with 
brain pathology often lead to loss of KCC2 and re-emergence of depolarizing GABAAR 
responses. The molecular mechanisms responsible for the up-regulation of KCC2 du-
ring development and those mediating its down-regulation, however, remain elusive.  
The present Thesis demonstrates that the low level of KCC2 protein in immature 
neurons is not a limiting factor for its functional activation. A single seizure episode 
induced with kainate triggers a fast transient enhancement of neuronal Cl- extrusion 
capacity paralleled by a large increase in surface-expressed but not total KCC2 protein 
in the hippocampus of neonatal rodents. This post-translational activation of KCC2 
appears to be mediated by BDNF-TrkB signaling, as evidenced by its sensitivity to Trk 
inhibition and its absence in BDNF knockout mice. In contrast to these fast changes in 
functional expression of KCC2, no requirement for endogenous BDNF was observed 
for the developmental up-regulation of KCC2 protein. Another key finding of this work 
is that down-regulation and inactivation of KCC2 following intense NMDA receptor 
(NMDAR) activation is mediated via cleavage and truncation of KCC2 by the calcium-
activated protease calpain. Importantly, the data obtained using inhibitors of protein 
degradation and protein synthesis indicate that the basal turn-over of KCC2 protein is 
slow and, consequently, down-regulation under pathological conditions is likely to 
result from enhanced degradation rather than from reduced de novo KCC2 synthesis. 
Together, the present findings highlight post-translational regulation as an important 
mediator of changes in the functional expression of KCC2 in response to conditions of 
enhanced neuronal activity, such as epileptic seizures. 
KCC2 has been traditionally regarded to have the most clearly defined physio-
logical role of all the K-Cl cotransporters, as it is uniquely expressed in central neurons, 
and determines the neuronal response to activation of GABAA and glycine receptors. 
However, such a view has changed drastically following the unexpected observation 
that  KCC2  has  also  a  structural role in the morphological maintenance of dendritic 
spines, one that is independent of its ability to transport ions. The intimate temporal 
coincidence between the developmental onset of KCC2 expression and the most intense 
phase of synaptogenesis during the brain growth spurt points to a possible role for this 
protein in synapse formation. Importantly, whether KCC2 plays a role in spinogenesis 
i.e. in induction of spines during the brain growth spurt has not been investigated so far. 
The results of the present work demonstrate that expression of KCC2 is not only a 
necessary but also a sufficient condition for the induction of functional glutamatergic 
spines during the brain growth spurt.  
The results of this work support the idea of KCC2 as an important synchronizing 
factor in the functional development of glutamatergic and GABAergic signaling. 
  
  
x 
 
  
  
1 
Introduction 
1 INTRODUCTION 
Recently, there has been an increasing 
interest in the indirect modulation of 
GABAergic responses in seizure disor-
ders with a therapeutic aim based on a 
strategy of targeting the plasmalemmal 
ion transporters responsible for the 
generation and maintenance of the ion 
gradients  that  drive  GABAAR-mediated 
currents (Löscher et al., 2013). This is 
motivated by the fact that short- and 
long-term changes in the functional 
properties  of  ion  transporters  have  a  
major influence on GABAergic signal-
ing during neuronal maturation and also 
following  trauma  and  seizures  (Fig.  1;  
Payne et al., 2003; Blaesse et al., 2009; 
Deeb et al., 2012; Löscher et al., 2013). 
Notably, standard antiepileptic drugs 
(AEDs), such as phenobarbital and 
benzodiazepines, which enhance GA-
BAergic transmission by directly target-
ing GABAARs are less effective in sup-
pressing seizures in neonates than in 
adults  (Painter  et  al.,  1999;  Booth  and  
Evans, 2004), and may lose their effica-
cy in parallel with seizure progression in 
adults as well (Wasterlain et al., 2009). 
The reasons for either of these are not 
fully understood.  
Immature neurons show low func-
tional expression of the main neuron-
specific Cl- extruder KCC2 which is 
associated with depolarizing and some-
times even excitatory actions of GABA 
on postsynaptic neurons. During neu-
ronal maturation, the expression and 
functionality of KCC2 are progressively 
increased, which is the basis for the 
generation of classical hyperpolarizing 
inhibitory postsynaptic potentials 
(IPSPs; Rivera et al., 1999). In rodent 
hippocampal and neocortical neurons, 
the ‘developmental shift’ from depolar-
izing to hyperpolarizing GABAAR-
mediated responses takes place postna-
tally (Rivera et  al.,  1999; Ben-Ari et  al.,  
2007; Blaesse et al., 2009; Fig. 1), and 
the  lack  of  efficacy  of  drugs  such  as  
phenobarbital in human neonates has 
often been attributed to the lack of 
KCC2 (cf. e.g. Dzhala et al., 2005; 
Staley, 2006; Glykys et al., 2009). 
In  addition  to  its  critical  role  as  a  
prerequisite for the activity-suppressing 
action of the main inhibitory neuro-
transmitters GABA and glycine, KCC2 
was recently demonstrated to play a 
vital, ion transport-independent, role in 
the morphological maintenance of the 
dendritic spine, the main target of the 
excitatory glutamatergic afferent in 
mature neurons. While genetic 
deficiencies of KCC2 in animals result 
in increased excitability (Blaesse et al., 
2009), it is unclear to what extent this is 
attributable to the structural versus 
transport roles of KCC2, suggesting that, 
unlike specifically enhancing the 
transport activity of KCC2, elevating 
KCC2 protein levels by gene therapy 
might  not  be  a  useful  therapeutic  
strategy.  
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2 REVIEW OF THE 
LITERATURE 
 IONIC BASIS OF GABAAR- 2.1
AND GLYR-MEDIATED 
SIGNALING 
Electrical signals in the brain are essen-
tially mediated by means of dissipation 
of ion transporter-generated transmem-
brane ion gradients following voltage- 
and neurotransmitter-gated opening of 
ion channels. The main inhibitory neuro-
transmitters  of  the  CNS,  GABA  at  su-
praspinal pathways and glycine in the 
brainstem and spinal cord, act on anion 
channel receptors primarily permeable to 
Cl- but  also  to  HCO3- (Bormann  et  al.,  
1987; Kaila and Voipio, 1987; Kaila et 
al., 1993; Kaila, 1994; Ikeda et al., 
2004). The electrochemical gradient of a 
given ion species is set by the activities 
of plasmalemmal transport mechanisms 
and the gradient-dissipating conductive 
channels. The ion gradient is the poten-
tial energy for ion movement stored in 
the chemical potential of the transmem-
brane concentration gradient and the 
transmembrane voltage difference. 
When the chemical and electrical forces 
governing the net movement of ions 
across the cell membrane are equal and 
opposite, no transmembrane charge 
transfer by the ion species takes place. 
The membrane potential difference at 
this energy equilibrium is defined as the 
equilibrium potential Ei for the current Ii 
carried by the given ion (i) species. 
Increasing the membrane conductance 
by opening channels selectively permea-
ble to ion species i drives the membrane 
potential Vm towards  Ei. While the 
amount of the ionic current, 
Ii = Gi(Vm - Ei) depends on the ionic 
conductance Gi and the driving force 
(DFi = Vm - Ei),  where  Gi is determined 
by the number and properties of ion 
channels, and DFi is generated by the 
action of plasmalemmal ion transport 
mechanisms. Importantly, DFi is respon-
sible for setting the polarity i.e. direction 
of  Ii. Thus, ion transporters of excitable 
cells are in a position to determine both 
the quantitative as well as the qualitative 
consequences of ion-channel mediated 
signaling.  
GABAAR and GlyR-mediated hy-
perpolarization of the membrane poten-
tial to a level more negative than the 
resting  Vm requires  the  presence  of  an  
active Cl- extrusion mechanism (Kaila, 
1994). The transmembrane electrochem-
ical Cl- gradient  i.e.  the  DF  for  
GABAAR- and GlyR-mediated inhibito-
ry postsynaptic potentials (IPSPs), is 
generated by secondary active K-Cl 
cotransport (Thompson et al., 1988), 
which was later shown to be largely 
mediated by the neuron-specific K-Cl 
cotransporter KCC2 (Rivera et al., 1999; 
Hübner et al., 2001b; Zhu et al., 2005; 
Blaesse et al., 2009; Seja et al., 2012). 
KCC2 is initially expressed at very low 
levels in the developing central nervous 
system (Blaesse et al., 2009), which fully 
accounts for the lack of hyperpolarizing 
responses to GABA observed in imma-
ture neurons which do not express KCC2 
or other Cl- extruding mechanisms 
(Fig. 1; Rivera et al., 1999; Blaesse et 
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al., 2009). It is obvious, however, that 
the presence of additional mechanisms, 
such as Na-K-2Cl cotransport mediated 
by NKCC1 (see section 2.2), which 
actively accumulate Cl-, are required for 
a Cl--dependent depolarization of  the  
membrane potential following GABAAR 
or GlyR activation (Fig. 1). 
GABAAR-mediated depolarization 
is, however, not always an indication of 
active Cl- accumulation because 
GABAARs  are  not  solely  permeable  to  
Cl- (Kaila, 1994). The term reversal 
potential Er, often inappropriately used 
synonymously with the equilibrium 
potential Ei, is equal to Ei only if a chan-
nel is ideally permeable to one ion spe-
cies only. Thus, the reversal potential for 
currents mediated by GABAARs 
(EGABA-A), receptor channels permeable 
to both Cl- and HCO3-, is determined by 
the electrochemical gradients and by the 
relative permeabilities of these ions:  
??????? = ??? ?? ????[???]?? + ??????[?????]??????[???]??? + ??????[?????]??? 
 
 
 
 
 
 
 
 
 
While the relative ionic permeability of 
GABAARs is larger for Cl- than for 
HCO3- (PHCO3-/PCl-?? 0.2-0.3; Kaila, 
1994), it is evident from the above equa-
tion that contribution of HCO3- to the 
value  of  EGABA-A can be substantial in 
neurons with low [Cl-]i, typically mature 
neurons, and EGABA-A can therefore 
significantly deviate from ECl- towards 
the more depolarizing EHCO3- (see 
Farrant and Kaila, 2007), especially 
during intense GABAAR activation leads 
to  a  HCO3--dependent intracellular ac-
cumulation of Cl- (Kaila, 1994; Viitanen 
et al., 2010). In contrast, the contribution 
of HCO3- to  EGABA-A is minimal in neu-
rons  with  high  [Cl-]i, such as immature 
neurons which often lack the capacity to 
extrude Cl-.  
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 CATION-CHLORIDE 2.2
COTRANSPORTERS 
KCC2 is a member of the SLC12A 
electroneutral cation-chloride cotrans-
porter (CCC) family, which in turn is 
part of the solute carrier (SLC) super-
family comprising ~300 transporter 
proteins (Hediger et al., 2004). SLC 
transporters are expressed in the plasma 
membrane and in the membranes of 
intracellular compartments of virtually 
all  cells  and  organelles,  where  they  
control uptake or efflux of sugars, amino 
acids (aa), nucleotides, ions, and drugs. 
Active translocation of solutes across 
cell membranes is mediated by primary 
active adenosine triphosphate (ATP)-
driven transporters, such as the Na-K 
ATPase, and secondary active transpor-
ters that couple the energetically favora-
ble ‘downhill’ solute electrochemical 
gradients, generated by primary active 
transporters, to the transport of other 
solute species ‘uphill’ across cell mem-
branes. The mammalian SLC12A family 
in humans and rats is encoded by the 
genes SLC12A1-9/Slc12a1-9. The gene 
products of SLC12A1-7 are secondary-
active electroneutral cation-Cl sympor-
ters that couple the energy stored in 
the Na+ and/or K+ electrochemical  
transmembrane gradients generated by 
the Na-K ATPase to actively transport 
Cl- across the plasma membrane 
(Blaesse et al., 2009; Gagnon and 
Delpire, 2013). CCCs are 1000-1200 aa 
glycoproteins of 120-200 kDa, and their 
Figure 1. A shift from depolarizing to hyperpolarizing GABAA receptor (GABAAR)-mediated Cl
- currents 
takes  place  during  neuronal  development,  and  an  opposite  effect  is  often  seen  following  epilepsy  and  
trauma. In  cortical  and  hippocampal  neurons,  the  Na-K-2Cl  cotransporter  isoform  1  (NKCC1)  mediates  Cl- 
uptake,  while  the K-Cl  cotransporter  isoform 2 (KCC2) extrudes Cl-. The energy for both of these electrically 
neutral  ion-transport  processes  is  derived  from  the  ion  gradients  generated  by  the  Na-K  ATPase.  NKCC1  is  
driven by the Na+ concentration gradient and KCC2 by the K+ gradient.  In  immature neurons (left)  GABAAR-
mediated Cl- currents are depolarizing. During neuronal development, up-regulation of KCC2 (rightward arrow) 
renders GABAAR-mediated Cl
- currents hyperpolarizing (right). Exposure of neurons to recurrent seizures and 
other  traumatic  insults  can lead to  down-regulation of  KCC2 and to  a  re-establishment  of  NKCC1-dependent  
depolarizing GABAergic signaling.  
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predicted structure, so far confirmed 
only for SLC12A2 (Gerelsaikhan and 
Turner, 2000; Payne, 2012), comprises a 
short N-terminal and a long C-terminal 
domain, 12 transmembrane spanning 
domains, and an extracellular loop con-
taining putative glycosylation sites 
(Gamba, 2005; Arroyo et al., 2013). 
Based on both their transport properties 
and amino acid sequences the CCCs can 
be divided in two groups (Gagnon and 
Delpire, 2013), (i) the Na+-dependent Cl- 
importers and (ii) the K+-dependent Cl- 
extruders. Na-K-2Cl cotransporter 
isoforms  1  and  2  (NKCC1;  SLC12A2 
and NKCC2; SLC12A1) and the Na-Cl 
cotransporter (NCC; SLC12A3) exploit 
the inwardly-directed Na+ electrochemi-
cal gradient to import Cl- into cells. K-Cl 
cotransporter isoforms 1-4 (KCC1-4; 
SLC12A4-7) use the outwardly-directed 
K+ gradient  to  extrude  Cl- from the cell 
interior.  
Because the CCCs transfer an 
equal number of cations and anions per 
transport cycle, their operation does not 
result in net charge movement across the 
plasma membrane rendering them elec-
troneutral. In contrast, the 3Na+/2K+ 
antiport stoichiometry of the 
Na-K ATPase is electrogenic and gives 
rise to an outward current. The electro-
neutral mode of CCC is particularly 
important in the context of excitable 
cells, such as muscle and nerve, as it 
enables regulatory control over intracel-
lular anion activity and cell volume 
without affecting the membrane poten-
tial (Payne, 2012). CCCs are expressed 
in all organ systems and are critical for a 
wide range of physiological processes, 
including cell volume regulation, trans-
epithelial transport of solute and water, 
blood pressure regulation, and regulation 
of intraneuronal Cl- concentration 
(Hebert et al., 2004; Gamba, 2005; 
Blaesse et al., 2009; Arroyo et al., 2013; 
Gagnon and Delpire, 2013). Disease-
related alterations in CCC-functionality 
have been implicated as part of several 
etiologically heterogeneous diseases, 
including arterial hypertension, osteopo-
rosis, cancer, and epilepsy (Gamba, 
2005). Pharmacological antagonists of 
some  of  the  CCCs  are  among  the  most  
commonly used drugs in medicine 
(Bartholow, 2012) and they, most notab-
ly, include the loop and thiazide diuret-
ics, which are indicated for a variety of 
fluid-balance disturbance-related condi-
tions, such as hypertension, glaucoma, 
and edema (Sarafidis et al., 2010; 
Pacifici, 2012). In addition to their clini-
cal use, the loop diuretics furosemide 
and bumetanide have proven to be valua-
ble tools for research on KCCs and 
NKCCs. Bumetanide at low micromolar 
concentrations can be used to selectively 
inhibit NKCCs, while bumetanide and 
furosemide concentrations in the milli-
molar range non-selectively antagonize 
both K-Cl and Na-K-2Cl cotransport 
(Adragna et al., 2004; Löscher et al., 
2013). A major limitation in studies on 
K-Cl cotransport has been the absence of 
selective inhibitors (Adragna et al., 
2004). Recent high throughput screening 
of potential drug candidates has identi-
fied small-molecule inhibitors for the 
neuron-specific KCC isoform (Delpire et 
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al., 2009; Lindsley et al., 2010), how-
ever, characterization of the off-target 
actions of such molecules is still in 
progress (Delpire et al., 2012). 
The clinical relevance of CCCs 
was highlighted following the identifica-
tion of a number of mutated SLC12A 
genes in several human Mendelian disea-
ses (Gamba, 2005; Arroyo et al., 2013). 
These include Bartter syndrome type I 
and Gitelman syndrome, both of which 
are characterized by low blood pressure 
due to renal failure and hypokalemic 
alkalosis, involving mutations in 
NKCC2 and NCC, respectively (Simon 
et al., 1996a; Simon et al., 1996b); as 
well as Andermann syndrome, a severe 
peripheral neuropathy with agenesis of 
the corpus callossum that involves mu-
tations in KCC3 (Howard et al., 2002; 
Rudnik-Schoneborn et al., 2009). Alt-
hough no human diseases have so far 
been directly linked to mutations in 
either  NKCC1  or  KCCs  other  than  
KCC3 (Rudnik-Schoneborn et al., 2009), 
phenotypes  of  mice  with  full  or  partial  
genetic disruptions in CCCs (for review, 
see Blaesse et al., 2009; Gagnon and 
Delpire, 2013) exhibit inner ear dysfunc-
tion  (NKCC1,  KCC3,  KCC4;  Delpire  et  
al., 1999; Flagella et al., 1999; Howard 
et al., 2002; Boettger et al., 2002; 
Boettger et al., 2003), blood pressure 
regulation impairments (NKCC1, KCC3; 
Flagella et al., 1999; Rust et al., 2006), 
as well as reduced threshold for seizure 
generation (KCC2; KCC3; Woo et al., 
2002 Boettger et al., 2003), and genera-
lized seizures (KCC2 [splice variant 
KCC2b; see below]; Woo et al., 2002).  
Apart from NCC and NKCC2 which are 
predominantly expressed in the kidney 
(Gamba  et  al.,  1994;  Mastroianni  et  al.,  
1996) all other CCCs are expressed at 
some stage in mammalian CNS devel-
opment (Fig. 2; Blaesse et al., 2009; 
Arroyo et al., 2013). The ubiquitously 
expressed NKCC1 is present neurons of 
rodents (Delpire et al., 1994; Plotkin et 
al., 1997a; Kanaka et al., 2001; Li et al., 
2002) and humans (Munoz et al., 2007; 
Hyde  et  al.,  2011).  Descriptions  of  the  
developmental expression patterns of 
NKCC1 in the CNS have been contro-
versial. Plotkin et al. (1997b) first re-
ported that a developmental peak in 
NKCC1 expression is reached in the rat 
forebrain around the first postnatal week, 
and down-regulation of NKCC1 mRNA 
and protein takes place thereafter (see 
also Wang et al., 2002). Such data is also 
in line with a reported shift from pre-
dominantly neuronal to largely glial 
expression of NKCC1 mRNA during 
CNS development in mouse (Hübner et 
al., 2001a), although, curiously, no 
NKCC1 protein was detected in glial 
cells by Plotkin et al. (1997a). In con-
trast, no developmental down-regulation 
of NKCC1 mRNA was observed by 
Clayton  et  al.  (1998)  in  the  rat  cortex.  
The authors suggested that the loss of 
NKCC1 expression observed by Plotkin 
et al. (1997b) may actually reflect 
changes in the alternative splicing and 
not expression of NKCC1, as the region 
of NKCC1 mRNA and protein detected 
by the oligonucleotide probes and anti-
bodies used by Plotkin et al. (1997b) was 
found to participate in alternative splic-
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ing  (see  Randall  et  al.,  1997).  In  the  
human CNS, no down-regulation, but 
rather progressive up-regulation of 
NKCC1 mRNA across the entire life-
span has been demonstrated (Hyde et al., 
2011; see also Szabadics et al., 2006; 
Munoz et al., 2007; Fig. 2). Such data is 
not, however, sufficient to yield infor-
mation regarding the functional roles of 
NKCC1, as the subcellular expression 
pattern of NKCC1 seems to determine 
its physiological actions (cf. O'Donnell 
et al., 2004; Khirug et al., 2008; Bos et 
al., 2011). However, the lack of specific 
NKCC1 antibodies has complicated the 
interpretation of immunochemical stud-
ies  on  the  subcellular  distribution  of  
NKCC1  (Blaesse  et  al.,  2009).  For  ex-
ample, Marty et al. (2002), reported 
localization change of NKCC1 from 
soma to dendrites in hippocampal py-
ramidal neurons during postnatal life, yet 
later electrophysiological work on 
NKCC1 knockout (KO) animals pin-
pointed the importance of this trans-
porter in the regulation of GABAergic 
signaling at the axon initial segment of 
neocortical and hippocampal principal 
neurons (Khirug et al., 2008; see also 
Szabadics et al., 2006).  
Among the KCCs, only the expres-
sion of KCC2 is restricted to central 
neurons (Payne et al., 1996; Williams et 
al., 1999; Rivera et al., 1999; Karadsheh 
and Delpire, 2001; Uvarov et al., 2005) 
and it is also the major KCC isoform 
expressed in the mature rodent and 
human CNS (Fig. 2; Rivera et al., 1999; 
Boettger et al., 2003; Karadsheh et al., 
2004; Blaesse et al., 2009; Seja et al., 
2012). Although KCC2 is broadly ex-
pressed among neurons of the adult 
CNS, certain neuronal subpopulations, 
including the dopaminergic neurons of 
substantia nigra (Gulacsi et al., 2003), 
vasopressinergic neurons of the dorso-
lateral part of the paraventricular nucleus 
(Kanaka et al., 2001; Haam et al., 2012), 
of  the  dorsomedial  part  of  the  suprachi-
asmatic nucleus (Kanaka et al., 2001; 
Belenky et al., 2008; Belenky et al., 
2010), reticular thalamic neurons 
(Kanaka  et  al.,  2001;  Bartho  et  al.,  
2004), neurons of the medial habenular 
nucleus (Kanaka et al., 2001; Wang et 
al., 2006; Kim and Chung, 2007), as well 
as the neurons of the mesencephalic 
trigeminal nucleus (Kanaka et al., 2001; 
Toyoda et al., 2005) have been reported 
to lack KCC2.  
The ubiquitously expressed KCC1 
is often considered as a ‘housekeeping’ 
isoform involved in cell volume regula-
tion (Hebert et al., 2004), however, in 
central neurons it appears to be ex-
pressed at very low levels (Payne et al., 
1996; Rivera et al., 1999; Kanaka et al., 
2001; Li et al., 2002; Rust et al., 2007). 
Similarly, except during the embryonic 
phase,  the  CNS  expression  of  KCC4  is  
limited (Karadsheh et al., 2004). The 
relatively high mRNA expression of 
both KCC1 and KCC4 during early 
embryonic development in the rodent (Li 
et  al.,  2002)  and  human (Fig.  2)  CNS is  
an intriguing observation that prompts 
future investigation. KCC3 is alterna-
tively spliced producing three variants. 
Of these, KCC3a and KCC3c are ex-
pressed in glia and neurons, respectively, 
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while KCC3b is found outside the CNS 
(Le  Rouzic  et  al.,  2006;  Blaesse  et  al.,  
2009).  
In the rodent CNS the expression 
of both KCC2 and KCC3 is up-regulated 
during  CNS  development  (Rivera  et  al.,  
1999; Pearson et al., 2001; Blaesse et al., 
2009). Although up-regulation in the 
expression of both KCC2 and KCC3 
temporally coincides with the emergence 
of hyperpolarizing GABAAR and GlyR-
mediated responses (Ben-Ari et al., 
2007; Blaesse et al., 2009), functional 
up-regulation of KCC2 appears both 
necessary (Rivera et al., 1999) and suffi-
cient (Lee et al., 2005) to account for the 
 
 
observed qualitative change in GABA-
ergic signaling in principal neurons. 
Indeed, based on a recent knockdown 
study, performed in cerebellar Purkinje 
and granule cells, the contribution of 
KCC3 to the total neuronal Cl- extrusion 
capacity is small compared to KCC2 
(Seja et al., 2012; see also Boettger et 
al., 2003). The relatively higher expres-
sion of KCC2 compared to KCC3 is also 
likely to be explained by the striking 
finding that KCC2, not KCC3, is re-
quired for the morphological maturation 
of cortical dendritic spines, in a manner 
that is independent of its ability to 
transport ions (Li et al., 2007; see section 
2.3.1).  
? ?
Figure 2.  Expression profiles  of  the SLC12A1-7 gene products in the human neocortex. Average fits of 
log2-transformed exon array signal intensity data from the Human Brain Transcriptome data bank 
(www.hbatlas.org; cf. Kang et al., 2011). Broken vertical line denotes approximate time of birth. 
 
  
9 
Review of the literature 
 KCC2  2.3
KCC2 is a glycoprotein with a predicted 
topology of 12 transmembrane domains, 
an N-glycosylated (where N is amino 
acid asparagine) extracellular domain 
between the 5th and  the  6th transmem-
brane domains, and two intracellular 
domains, a smaller (~100 aa) N-terminal 
domain (NTD) and a larger (~480 aa) 
C-terminal domain (CTD), which flank 
the transmembrane domains and together 
account approximately for half of the 
size of the KCC2 molecule (1116 aa; 
Fig.  3).  Deletion  of  the  NTD (aa  1-100;  
KCC2 ?NTD) renders KCC2 transport-
inactive in neurons and HEK-293 cells, 
while at least the latter are able to ex-
press the ?NTD variant at the cell mem-
brane  (Li  et  al.,  2007).  Similarly,  the  
CTD is necessary for the K-Cl cotrans-
port function (Mercado et al., 2006; 
Acton et al., 2012). Especially the latter 
of the two terminal domains has been 
identified as critical cytoplasmic target 
for post-translational regulation of 
KCC2. The majority of the phosphoryla-
tion sites predicted for KCC2 appear in 
its CTD (Song et al., 2002; Chamma et 
al., 2012) and several of these residues 
have been implicated in regulatory phos-
phorylation of KCC2 during develop-
ment and in response to neuronal activity 
(Chamma  et  al.,  2012;  Kahle  et  al.,  
2013).  
The mammalian KCC2 gene is 
N-terminally spliced to produce two 
neuron-specific isoforms, KCC2a and 
KCC2b, with comparable co-transport 
properties (Uvarov et al., 2007). KCC2b 
has been established as the major iso-
form contributing to almost 90% of total 
KCC2 protein in the adult murine cortex 
(Uvarov  et  al.,  2007;  Uvarov  et  al.,  
2009). While the expression of KCC2a 
remains relatively low throughout devel-
opment, the expression of KCC2b is 
strongly up-regulated during postnatal 
life  (Stein  et  al.,  2004;  Uvarov  et  al.,  
2007; Uvarov et al., 2009). A particular-
ly high increase in KCC2b expression 
has been observed in mouse hippocam-
pal and cortical regions, where KCC2b 
mRNA is up-regulated 10- and 35-fold, 
respectively, between embryonic day 
(E) 17 and postnatal day (P) 14 (Uvarov 
et al., 2007). The specific disruption of 
KCC2b leads to a seizure phenotype, 
however such mice are viable until the 
third postnatal week (Woo et al., 2002; 
Uvarov  et  al.,  2007;  cf.  Blaesse  et  al.,  
2009). Thus, the genetic disruption of 
KCC2-mediated neuronal Cl- extrusion 
is  not  lethal  at  birth  as  was  originally  
thought (Hübner et al., 2001b).  
 
  
10 
Review of the literature 
  
Figure  3. KCC2 functions are regulated by transcriptional control, subcellular targeting, and post-
translational modifications such as protein phosphorylation. Upper left Transcriptional  control  of  KCC2  
expression in central neurons is mediated by several, most likely redundant, regulatory mechanisms. Lower 
left While protein 4.1N is involved in the anchoring of spine KCC2 to the cytoskeleton, it is not clear whether 
this  is  true  for  KCC2  located  in  dendritic  shafts  and  neuronal  somata  (indicated  by  a  question  mark).  The  
mechanisms whereby KCC2 is  excluded from the axon and NKCC1  targeted to  the axon initial  segment  are  
unclear. Lower right Kinases and phosphatases acting on the phosphorylatable residues of KCC2 (see inset 
upper right; e.g. PKC acting on S940) can modify KCC2 function by influencing the relative rates of endo- and 
exocytosis. The lack of evidence (indicated by a question mark) for direct modulation of the intrinsic rate of 
ion transport of neuronal CCCs is highlighted. Modified with permission from Blaesse et al. (2009). Inset with 
KCC2 diagram (and notable putative phosphorylation sites and the “ISO” domain) adapted, with permission, 
from Kahle et al. (2013).  
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2.3.1 FUNCTIONS OF KCC2 
During neuronal development, depolar-
izing GABAergic signaling promotes the 
opening of voltage-gated Ca2+ channels, 
activation of NMDARs and sometimes 
the firing of action potentials. The result-
ing transient elevations in [Ca2+]i and 
activation of downstream signaling 
cascades underlie the trophic effects of 
depolarizing GABAergic signaling 
during development (Ben-Ari et al., 
2007). These effects have been observed 
in vitro at numerous levels of neuronal 
and network development, ranging from 
synthesis  of  DNA to  neuronal  prolifera-
tion, migration, and morphological 
maturation of neurons and synapses 
(Represa and Ben Ari, 2005; Blaesse et 
al., 2009). The loss of depolarizing and 
acquisition of hyperpolarizing 
GABAAR-mediated signaling through 
functional up-regulation of KCC2 is 
believed  to  bring  to  an  end  the  trophic  
effects  of  depolarizing  GABA  (cf.  
Akerman and Cline, 2006; Cancedda et 
al., 2007; Bortone and Polleux, 2009).  
The functions of KCC2 in neurons 
have been studied using in vitro and in 
vivo models where KCC2 has been 
either disrupted or overexpressed. Such 
work has linked KCC2 to formation and 
function of GABAergic and glutama-
tergic synapses (for review, see Blaesse 
et al., 2009; Chamma et al., 2012). Orig-
inal work using antisense oligonucleo-
tide knockdown of KCC2, first defined 
the causal role for KCC2 in the genera-
tion of the driving force for hyperpolar-
izing  actions  of  GABA  (Rivera  et  al.,  
1999). Later, a second structural func-
tion, one that is independent of ion 
transport, was demonstrated for KCC2 
using transport-inactive variants of 
KCC2 in the morphogenesis of glutama-
tergic synapses (Li et al., 2007; see also 
Horn et al., 2010). Consequently, in light 
of this recent finding, many effects 
concluded in an a priori manner to arise 
from changes in KCC2-mediated Cl- 
extrusion may in fact partly or fully be 
accounted  for  by  the  structural  roles  of  
KCC2. For instance, the KCC2-C568A 
mutant used by Cancedda et al. (2007) 
and Reynolds et al. (2008) to support the 
idea that premature expression of KCC2-
mediated Cl- extrusion disrupts neuronal 
development, was later found to be 
unable not only of ion transport 
(Reynolds  et  al.,  2008;  Puskarjov  et  al.,  
unpublished) but also of interactions 
with the actin  cytoskeleton  (Horn  et  al.,  
2010). Thus, in attempts to infer the 
roles of this multifunctional protein in 
CNS physiology  and  disease  states,  it  is  
imperative to consider both the contribu-
tion  of  ion  transport  as  wells  as  other  
functions of KCC2 that may be unrelated 
to K-Cl cotransport.  
 
Neuronal K-Cl cotransport 
K-Cl cotransport was initially identified 
in red blood cells (Kregenow, 1971; 
Dunham et al., 1980; Lauf and Theg, 
1980), where (and as later discovered in 
most other cells of the body) it is acti-
vated by hypotonic cell swelling and 
mediates regulatory volume decrease 
through an efflux of K+, Cl- and osmoti-
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cally obliged water. Compared to the 
other KCC isoforms, which are exclu-
sively swelling activated, the neuron-
specific isoform KCC2 is unique as it is 
capable of constitutive K-Cl cotransport 
under isotonic conditions (Payne, 1997; 
Song et al., 2002; Gamba, 2005; 
Mercado et al., 2006). This important 
feature of KCC2 has been pinpointed to 
a unique stretch of amino acids termed 
the “ISO domain” and located in the 
distal C-terminus of the transporter (Fig. 
3; Mercado et al., 2006). Deletion of the 
KCC2 ISO domain in neurons leads to 
loss  of  Cl- extrusion under isotonic 
conditions whilst apparently sparing that 
induced by experimentally-induced 
hypotonic shock (Acton et al., 2012). 
However, physiologically-induced swell-
ing of neurons results from activity-
dependent ionic loads, not from hypo-
tonic stress (Gulyas et al., 2001; Payne et 
al., 2003). Thus, massive synaptic activi-
ty and excitotoxic conditions are thought 
to lead to neuronal swelling caused by an 
enhanced cellular ionic influx which is 
accompanied by the net movement of 
water (Choi, 1987; Allen et al., 2004). In 
contrast, under hypotonic conditions, the 
intracellular solute level is reduced 
(Basavappa and Ellory, 1996), and under 
these conditions the volume of glial but 
not  of  neuronal  cells  is  likely  to  be  af-
fected, due to the apparent lack of aqua-
porins in neurons (Amiry-Moghaddam 
and Ottersen, 2003). The abundant ex-
pression of KCC2 near excitatory synap-
ses in hippocampal neurons has been 
proposed to limit dendritic swelling in 
response to intense glutamatergic signal-
ing (Gulyas et al., 2001). However, 
experimental tests of this hypothesis are 
lacking. Nonetheless, the exclusive 
ability of KCC2 among the KCCs, to 
extrude Cl- under isotonic conditions 
(Gamba, 2005), supports the conclusion 
that it is the major functional KCC iso-
form in neurons. The salient develop-
mental expression profile of KCC2b, 
together with the fact that GABAergic 
responses in cultured cortical neurons 
from KCC2b-specific KO mice remain 
depolarizing (Zhu et al., 2005), indicates 
that the KCC2b isoform is responsible 
for the shift from depolarizing to hy-
perpolarizing GABAAR-mediated re-
sponses during development (Blaesse et 
al., 2009). 
Regarding the role of ion transport 
in controlling the efficacy of inhibition, 
the determining factor is the capability 
of KCC2 to maintain the GABAA driving 
force (DFGABAA = Vm - EGABA-A) at a 
sufficiently negative level to prevent the 
neuron from firing action potentials 
(Farrant and Kaila, 2007). The above 
does not necessarily stipulate hyperpo-
larizing levels, as an EGABA-A level that is 
close  to  resting  Vm or even slightly 
depolarizing does not imply an absence 
of an inhibitory GABAergic action. This 
is because the opening of GABAARs 
leads not only to a change in Vm towards 
EGABA-A, but also to shunting of excitato-
ry postsynaptic potentials (EPSPs), i.e. 
to a decrease in membrane resistance 
and a consequent decrease in the effica-
cy of EPSPs to sum up in space and in 
time and to reach the action potential 
threshold (Farrant and Kaila, 2007; 
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Bartos et al., 2007). An important dis-
tinction between voltage inhibition and 
shunting inhibition lies in the fact that 
the  latter  is  local  and  lasts  only  for  the  
duration of the change in synaptic con-
ductance i.e. as long as the GABAARs 
reside in an open and conductive state. 
In contrast, hyperpolarizing or depolariz-
ing synaptic potentials outlast the con-
ductance change that generates them, 
and their spread in space and time is 
determined by passive membrane prop-
erties and voltage-gated channels 
(Farrant and Kaila, 2007).  
The electroneutral transport mode 
of CCCs obviously precludes direct 
electrophysiological monitoring of their 
transport function in a manner used to 
assess electrogenic transporters. A nota-
ble  example  of  such  is  the  Na-K  
ATPase, the transport cycle of which 
generates an outward transmembrane 
current. Nevertheless, because the rever-
sal potential of GABAARs and GlyRs is 
strongly influenced by the mechanisms 
regulating [Cl-]i, these receptor channels 
can be used as indirect read-out devices 
for the assessment KCC2-mediated Cl- 
extrusion. Measurements of the steady 
state EGABA-A or EGly values can, howev-
er, at best provide information about the 
presence or absence of Cl- extrusion as, 
in the absence of a cellular Cl- load, even 
an inefficient extrusion mechanism is 
able to maintain a hyperpolarizing 
EGABA-A or  EGly (Jarolimek et al., 1999; 
Blaesse et al., 2009). Techniques involv-
ing an imposed Cl- load are thus war-
ranted to assess the capacity of a neuron 
to  extrude  Cl- (Jarolimek et al., 1999; 
Khirug et al., 2005; Jin et al., 2005; Zhu 
et al., 2005; Blaesse et al., 2009; Nardou 
et al., 2011b; Seja et al., 2012). The 
validity of this approach to assess 
changes in KCC2 function was well 
demonstrated by Prince and colleagues 
in cortical pyramidal neurons, where, in 
the absence of a Cl- load, even a marked 
damage-induced down-regulation of 
KCC2 function could not be detected by 
recordings of the steady-state EGABA-A 
(Jin et al., 2005). 
Because neurons in active net-
works in vivo are under constant barrage 
of excitatory and inhibitory inputs that 
promotes Cl- loading (Buzsaki et al., 
2007),  it  is  obvious  that  an  efficient  Cl- 
extruding mechanism such as KCC2 is a 
requirement for maintaining EGABA-A 
below action potential firing threshold in 
such cells. However, under conditions of 
strong GABAAR activation, high eleva-
tions in [Cl-]i, generated by a large elec-
trogenic uptake of Cl- driven by efflux of 
HCO3- through  GABAARs, have been 
demonstrated to promote generation of 
depolarizing extracellular [K+] transients 
via KCC2 (Viitanen et al., 2010). Thus, 
under conditions of intense GABAAR 
activation, such as during bursts of ictal 
activity, KCC2 may paradoxically act as 
a mediator of excitatory GABAAR sig-
naling (Kaila et al., 1997; Viitanen et al., 
2010; see also Miles et al., 2012; Pavlov 
et al., 2013).  
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Ion transport-independent roles of 
KCC2 
Work by Gulyas et al. (2001) first 
showed that a considerable part of KCC2 
is associated with dendritic spine heads 
and bases of all hippocampal principal 
cells and parvalbumin-positive interneu-
rons, with a particularly high level in the 
thorny excrescences of CA3 neurons. In 
light of the notion that the vast majority 
of excitatory synapses are formed on 
dendritic spines and most inhibitory 
inputs are made onto dendritic shafts 
rather than spines (Somogyi et al., 1998; 
Hering and Sheng, 2001; Yuste, 2010), 
the high level of a key molecule for 
GABAergic transmission in the vicinity 
of glutamatergic synapses in spines 
(Gulyas et al., 2001) raised the question 
that perhaps ‘spine KCC2’ may have a 
role that is  not directly related to inhibi-
tory signaling.  
Li et al. (2007) were first to pro-
vide evidence for a role of KCC2 in the 
formation of excitatory synapses. Neu-
rons from organotypic or dissociated 
embryonic cortical cultures from KCC2 
KO (KCC2-/-) mice exhibited elongated 
filopodia-like dendritic protrusions, 
instead of dendritic spines, and a reduced 
number of functional excitatory synap-
ses. The latter was seen as a reduction in 
synaptic clusters, in the number of active 
presynaptic elements as well as in the 
frequency of miniature excitatory 
postsynaptic currents (mEPSCs; Li et al., 
2007). Importantly, the authors also 
demonstrated that this effect was specifi-
cally attributable to the loss of KCC2 
function unrelated to ion transport. 
Transfection of day in vitro (DIV) 9 
KCC2-/- neurons with full-length KCC2 
(KCC2-FL) or with an N-terminally-
deleted transport-deficient KCC2 con-
struct  (KCC2-?NTD;  deletion  of  aa  1-
100) prevented the above effects of 
constitutive KCC2 disruption, observed 
on  DIV14,  while  transfection  with  GFP  
or KCC3 had no effect (Li et al., 2007). 
Accordingly, the impaired spine matura-
tion in KCC2-/- neurons was apparently 
not attributable to the lack of functional 
inhibition and consequent hyperexcita-
bility, as culturing these neurons in the 
continuous presence of the voltage-gated 
Na+ channel inhibitor tetrodotoxin 
(TTX) had no effect on the length of 
their dendritic protrusions (Li et al., 
2007; but see also Richards et al., 2005). 
For corroboration of the in vitro data, Li 
et al. (2007) utilized hypomorphic heter-
ozygous KCC2 mice (KCC2hy/-), which 
express ~20% of wildtype (WT) KCC2 
protein but, unlike the complete KO, 
they are viable (Tornberg et al., 2005). 
In cortical slices from KCC2hy/- mice the 
constitutively decreased KCC2 expres-
sion  was  associated  with  elongation  of  
dendritic protrusions, albeit to a much 
lesser extent than that seen in KCC2-/- 
cultures (Li et al., 2007). Alterations in 
the density of dendritic protrusions were 
observed neither in vitro in cultured 
KCC2-/- cortical neurons at DIV14, nor 
in ex vivo cortical neurons from P16 
KCC2hy/- mice (Li et al., 2007). Knock-
down of KCC2 starting from the second 
postnatal week in cerebellar Purkinje 
neurons in vivo using Cre-mediated exon 
  
15 
Review of the literature 
excision  (Seja  et  al.,  2012)  or  from  
DIV14 in cultured hippocampal neurons 
using siRNA (Gauvain et al., 2011) had 
no  effect  on  the  length  or  density  of  
dendritic protrusions, as seen in adult 
neurons from these preparations. Curi-
ously though, in the study by Gauvain et 
al., an increase in the proportion of 
mushroom-type spines was observed 
(see also Khalilov et al., 2011). When 
KCC2 was knocked down starting from 
DIV4,  i.e.  before  spine  formation,  a  
larger proportion of filopodia-type pro-
trusions but no change in the overall 
density of dendritic protrusions was 
observed  at  DIV14  (Gauvain  et  al.,  
2011). Moreover, recent data by Sun et 
al. (2013) demonstrated that the dramatic 
reduction  of  spine  density  of  DIV15  
primary mouse cortical neurons follow-
ing shRNA-mediated knockdown of the 
cell adhesion molecule neuroligin-2 
(NL-2), could be completely prevented 
by co-transfecting the neurons with 
NL2shRNA and FL-KCC2 at DIV2. 
Together these studies (Li et al., 2007; 
Gauvain et al., 2011; Seja et al., 2012; 
Sun et al., 2013), might suggest that 
expression of KCC2 may be required for 
the induction rather than for the mainte-
nance of  dendritic  spines.  However,  
further studies are required to investigate 
whether knocking KCC2 down after 
spine formation in hippocampal and 
cortical pyramidal neurons has an effect 
on spine maintenance under in vivo 
conditions. While no effect of such a 
manipulation on dendritic spines was 
observed in cerebellar Purkinje neurons 
(Seja et al, 2012), given the likelihood of 
fundamental differences in the mecha-
nisms of spine formation between py-
ramidal and Purkinje neurons (see Yuste 
and Bonhoeffer, 2004; Ethell and 
Pasquale, 2005), generalization of this 
observation to pyramidal neurons war-
rants caution. 
Using cultured hippocampal neu-
rons Gauvain et al. (2011) also found 
that chronic suppression of KCC2 ex-
pression after spine formation in vitro 
was associated with a reduction in 
mEPSC amplitude paralleled by in-
creased lateral diffusion of the AMPA 
receptor (AMPAR) GluR1 subunits in 
spines. The authors suggested that this 
effect was attributable to an ion 
transport-independent function of KCC2, 
as increased lateral diffusion of AM-
PARs was observed also after dominant-
negative expression of the C-terminal 
domain of KCC2 (KCC2-CTD; aa 637-
1116), but not following incubation of 
neuronal cultures with a recently synthe-
sized KCC2 cotransport inhibitor 
VU0244051 for longer than 72 hours 
(Gauvain et al., 2011). This conclusion 
warrants confirmation because it is 
largely based on the data obtained using 
a relatively long incubation with 
VU0240551 (Delpire et al., 2009), which 
has been reported to have significant off-
targets (Lindsley et al., 2010; Delpire et 
al., 2012), including inhibition of L-type 
Ca2+ channels  (LTCCs).  It  is  by  no  
means excluded that such off-target 
effects may play a role in the present 
context, as LTCCs are expressed hippo-
campal pyramidal neurons and actively 
partake in plasticity of dendritic spines 
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(cf. Matus, 2000; Obermair et al., 2004; 
Oertner and Matus, 2005; Nakata and 
Nakamura, 2007; Di Biase et al., 2011). 
One potential approach to assess the 
non-dependence of the effect of lateral 
diffusion of AMPARs on KCC2 
transport function would be to knock 
down endogenous KCC2 using shRNA 
against an N-terminal sequence of KCC2 
mRNA and attempt a rescue with an N-
terminally deleted KCC2 construct, such 
as the KCC2-?NTD, which is transport-
deficient but has been shown to interact 
with  the  cytoskeleton  (see  Li  et  al.,  
2007).  
Also  Li  et  al.  (2007)  reported  a  
dominant-negative effect of KCC2-CTD 
overexpression in cultured cortical neu-
rons,  but  this  was  on  the  length  of  den-
dritic protrusions. Transfection of WT 
neurons on DIV9 with KCC2-CTD led 
to an increase in protrusion length as 
observed on DIV14 that was comparable 
to what was observed in KCC2-/- neurons 
transfected  with  GFP  alone  (Li  et  al.,  
2007). However, no dominant-negative 
effect of KCC2-CTD on protrusion 
length was observed at DIV24 in hippo-
campal neurons that where transfected 
on DIV14 (Gauvain et al., 2011), sug-
gesting either dependence on the cell 
type or a restricted time window for the 
effect.  The  dominant  effect  of  KCC2-
CTD in particular, and the morphogenic 
effect of KCC2 in general, have been 
attributed to stem from the interaction of 
the C-terminal domain of KCC2 with the 
4.1N protein (Li et al., 2007; Horn et al., 
2010), a structural protein found in 
neurons that binds actin and crosslinks 
the spectrin/actin skeleton with trans-
membrane proteins (Bennett and Baines, 
2001; Baines et al., 2001; Denker and 
Barber, 2002). Interestingly, a point 
mutation (KCC2-C568A) located outside 
the C-terminal domain of KCC2 also 
renders KCC2 unable to bind 4.1N, to 
interact with the cytoskeleton (Horn et 
al., 2010), and to transport ions 
(Reynolds  et  al.,  2008;  Puskarjov  et  al.,  
unpublished). It is likely that this muta-
tion results in misfolding of KCC2 pro-
tein precluding its membrane expression 
and/or cytoskeletal interactions. 
While the landmark study of Li et 
al. (2007) established a novel primary 
function for KCC2, the ion transport-
independent role of KCC2 in synapto-
genesis is not clear cut. For instance, 
while early overexpression of KCC2, but 
not of a transport-deficient mutant 
(KCC2-Y1087D; Strange et al., 2000), 
resulted in reduced amplitude and fre-
quency of mEPSCs, in Xenopus tectal 
neurons (Akerman and Cline, 2006), 
overexpression of KCC2 in cultured 
hippocampal neurons had no effect on 
mEPSC frequency or amplitude or the 
density of glutamatergic terminals 
(Chudotvorova et al., 2005). In the latter 
study, overexpression of KCC2 was, 
however, reported to increase the fre-
quency of miniature inhibitory postsyn-
aptic currents (mIPSCs) and the density 
of GABAAR clusters (Chudotvorova et 
al., 2005). Surprisingly, a reduction in 
the frequency of mIPSCs but not of 
mEPSCs was reported in CA1 pyramidal 
neurons of KCC2 hypomorphic mice 
(Riekki et al., 2008). However, it is not 
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possible to assert, whether such effects 
of KCC2 overexpression or disruption 
on the properties of GABAergic synap-
ses are a result of KCC2 functions de-
pendent on K-Cl cotransport, on those 
independent of ion transport, or both. 
Intriguingly, an increased frequency of 
both spontaneous IPSCs and EPSCs in 
CA3 pyramidal neurons was observed in 
KCC2-/- mice already at E18.5, well 
before KCC2-mediated Cl- extrusion is 
up-regulated in these cells (Khalilov et 
al., 2011). The existence of an early 
embryonic ion-transport independent 
function of KCC2 in morphological 
maturation of neurons is also supported 
by  the  study  of  Horn  et  al.  (2010).  The  
authors of this work employed pronucle-
ar DNA injection of fertilized mouse 
oocytes with KCC2 constructs under the 
nestin promoter, limiting their expres-
sion to neuronal progenitors. They 
demonstrated that constitutive neuron-
specific overexpression of KCC2-FL or 
of the transport-deficient KCC2-?NTD, 
but not of KCC2-C568A (a mutant 
incapable of both ion transport and actin-
binding) severely impaired the develop-
ment of neural tube- and neural crest-
related structures, resulting in death of 
the implanted embryo at E13.5-15.5. 
Horn et al. (2010) also observed some-
thing that may shed light on the early ion 
transport-independent function of KCC2 
in the early embryonic CNS. The authors 
demonstrated not only aberrant cyto-
plasmic distribution of 4.1N and actin 
but also impairments in neuronal differ-
entiation and migration in the neural 
tube  of  embryos  overexpressing  FL-
KCC2, KCC2-?NTD but, again, not 
KCC2-C568A (Horn et al., 2010; see 
also  Wei  et  al.,  2011).  This  is  an  intri-
guing finding as premature expression of 
the transport active KCC2-FL but not of 
KCC2-?NTD has been shown to termi-
nate the postnatal migration of cortical 
interneurons (Bortone and Polleux, 
2009). However, no effects on migration 
but rather impairments in dendritic 
arborization of cortical pyramidal neu-
rons were reported following in utero 
electroporation at E17-18 of KCC2-FL, 
but not KCC2-C568A (Cancedda et al., 
2007).  
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2.3.2 EXPRESSION OF KCC2 
Most  of  the  data  published  on  the  
spatiotemporal expression patterns of 
KCC2  reflects  that  of  both  KCC2a  and  
KCC2b, as the mRNA probes and 
antibodies used do not differentiate 
between the two spice variants. 
Therefore in the present Thesis “KCC2” 
represents both splice variants (unless 
otherwise stated), except when referring 
to the study by Stein et al. (2004) where 
the antibody used was KCC2b-specific, 
although the authors were not aware of 
this  at  the  time  of  publication  of  the  
original study (cf. Uvarov et al., 2009). 
 
Ontogeny of KCC2 in rodents and 
humans 
In  all  of  the  many  species  studied,  
including humans, an almost invariant 
feature observed during development of 
the  CNS,  is  an  up-regulation  of  KCC2  
expression. However, in keeping with 
the general differences in the milestones 
of CNS development (cf. Clancy et al., 
2001; Erecinska et al., 2004b; Semple et 
al.,  2013),  also  the  timing  of  KCC2  
induction appears to be species- and 
CNS  region-specific.  In  the  CNS  of  the  
mouse and the rat, two species most 
studied with this regard and the model 
species used in the present Thesis, KCC2 
is up-regulated strictly in parallel with 
neuronal differentiation, with a gradual 
increase in the caudal-to-rostral direction 
of the CNS (Li et al., 2002; Wang et al., 
2002; Stein et al., 2004).  
In  the  caudal  parts  of  the  rodent  CNS,  
such  as  the  spinal  cord  and  parts  of  the  
brainstem, perinatal KCC2 expression 
patterns are comparable to those 
observed in older animals (Balakrishnan 
et al., 2003; Stein et al., 2004; Blaesse et 
al., 2006; Uvarov et al., 2009). In the 
more  rostral  parts,  such  as  the  
hippocampus and the neocortex, a steep 
up-regulation of KCC2 mRNA 
commences by the time of birth (Rivera 
et al., 1999; Wang et al., 2002; Li et al., 
2002; Balakrishnan et al., 2003; Stein et 
al., 2004) and reaches a plateau around 
the third postnatal week (Rivera et al., 
1999; Wang et al., 2002).  
In the mouse hippocampus, no 
detectable KCC2 protein was observed 
prenatally using Western blotting (Stein 
et  al.,  2004).  However,  the  low  
resolution achieved with this technique 
may not detect the expression of KCC2 
at this stage in subpopulations of 
neurons (cf. e.g. Khalilov et al., 2011). 
Postnatally, a very low level of 
expression of KCC2 protein was seen in 
the ~P1-P4 mouse hippocampus (Stein et 
al., 2004; Blaesse et al., 2006; Zhu et al., 
2008), and has been estimated to 
increase ~4-fold between P6-9 (Liu et 
al., 2006) and ~3-fold between ~P6-20 
(Sipilä et al., 2009). Interestingly earlier 
expression has been reported in the CA1 
than in the neighboring CA3 region (Zhu 
et al., 2008).  
A similar picture prevails also in 
the rodent cerebral cortex, with very 
little KCC2 mRNA before birth, low but 
increasing levels during the first 
postnatal week, followed by robust up-
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regulation reaching adult levels during or 
soon after the third postnatal week 
(Clayton et al., 1998; Wang et al., 2002; 
Shimizu-Okabe et al., 2002; Ikeda et al., 
2003; Stein et al., 2004). KCC2 protein 
levels in the mouse neocortex appear 
very low perinatally up to P3-4, and 
increase robustly around the second 
postnatal week, as seen from Western 
blot data from the whole cortex (Stein et 
al., 2004; Sun et al., 2013) or 
immunohistochemical analysis of the 
somatosensory cortex (Takayama and 
Inoue, 2010; Kovacs et al., 2013). For 
example, a ~3-fold increase in KCC2 
protein level was seen in Western blots 
of the whole mouse neocortex between 
P4 and P16, reaching ~65% of the level 
observed at P20 (Sun et al., 2013). 
Immunohistochemical analysis of KCC2 
expression in the rat cortex during the 
first two postnatal weeks demonstrated 
presence of KCC2 already at birth in the 
piriform  and  entorhinal  cortices,  with  
gradually increasing expression in the 
superficial layers of the neocortex during 
the  first  postnatal  week.  By  the  end  of  
the first week an adult-like pattern of 
KCC2 expression, including discrete 
dendritic expression, was observed in 
cortical cells of all neocortical and 
paleocortical areas (Kovacs et al., 2013). 
All  these  observations  are  at  striking  
odds with a highly cited study (Dzhala et 
al., 2005) containing Western blot data 
obtained from an unspecified cortical 
region  of  the  rat  brain,  which  failed  to  
detect any KCC2 protein prior to P11. 
A default assumption in the vast 
majority of studies seems to be that in 
the rodent hippocampus, adult levels of 
KCC2 protein expression are reached 
during the third postnatal week, most 
commonly  around  P15  (Stein  et  al.,  
2004). However, this appears to be 
largely based on an extrapolation from a 
plateau  in  KCC2  mRNA  levels  
beginning around ~P15 (cf. Rivera et al., 
1999; Wang et al., 2002). To the best of 
my  knowledge,  the  only  report  so  far  
providing a direct quantitative 
comparison of total KCC2 protein levels 
at later time points in the mouse 
hippocampus demonstrated a ~2-fold 
increase in KCC2 protein levels between 
P15  and  P30  (Uvarov  et  al.,  2006;  see  
also Zhu et al., 2008). Nevertheless, after 
P15, no further increase in KCC2-
mediated Cl- extrusion  capacity  of  
mouse CA1 pyramidal neurons (Khirug 
et al., 2005), or additional shifts in 
EGABA-A or  DFGABA-A of  rat  CA3  
pyramidal neurons (Tyzio et al., 2008), 
were observed. Such observations 
suggest either a higher safety factor (cf. 
Diamond, 2002) for total cellular KCC2 
protein expression in older animals, and 
that part of the total KCC2 pool in these 
cells is not immediately contributing to 
Cl- extrusion at all. Obviously, these 
options are not mutually exclusive. 
Most  of  the  studies  on  the  devel-
opmental  shift  in  EGABA-A have been 
performed using rodents (Ben-Ari et al., 
2007). The timing of the EGABA-A shift in 
human CNS structures has not been 
identified. In altricious rodents such as 
rats and mice, the most intense phase of 
the developmental increase in KCC2 
protein, paralleled by a hyperpolarizing 
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shift in EGABA-A, takes place after birth 
during the first weeks of life (for review, 
see Ben-Ari et al., 2007). In contrast, in 
developmentally precocious species, 
such as the guinea pig, KCC2 mRNA 
up-regulation takes place already in 
utero and GABAAR-mediated responses 
are hyperpolarizing at birth (Rivera et 
al., 1999). Humans are conventionally 
regarded as an altricious species but, in 
terms of CNS development, human 
neonates are born at a much more ad-
vanced stage compared to rats and mice, 
which are born at a stage of cortical 
development which roughly corresponds 
to  that  of  the  second  half  of  human  
gestation (Clancy et al., 2001; Avishai-
Eliner et al., 2002; Erecinska et al., 
2004b; Khazipov and Luhmann, 2006; 
Semple et al., 2013). Analysis of several 
GABAergic parameters in standardized 
regions of the human cerebral cortex has 
demonstrated that the period from the 
second half of gestation to early infancy 
is a critical period for rapid development 
of the cortical GABAergic system (Xu et 
al., 2011). Notably, in human preterm 
babies changes in the properties of the 
electroencephalogram (EEG) parallel up-
regulation of KCC2 mRNA, and in the 
healthy human newborn the salient EEG 
properties correspond to a developmen-
tal stage in rodents where GABAergic 
signaling is no longer depolarizing 
(Vanhatalo et al., 2005). Furthermore, a 
study on the macaque hippocampus ex 
utero has demonstrated that epileptiform 
discharges can be evoked by GABAAR 
antagonism by the last third of gestation 
(Khazipov et al., 2001), which roughly 
corresponds to the middle of the second 
trimester in humans (Clancy et al., 
2001). Little KCC2 immunostaining is 
observed in the human neocortex before 
midgestation (Bayatti et al., 2008; Wang 
et al., 2010), and the above functional 
inferences  as  well  as  analyses  of  KCC2  
expression patterns (Fig. 2; Vanhatalo et 
al., 2005; Bayatti et al., 2008; Hyde et 
al., 2011) suggest that a robust increase 
in KCC2 protein takes place during the 
second half of gestation and continues 
postnatally. This is in striking contrast to 
a study reporting strictly postnatal ex-
pression of KCC2 protein in human 
parietal cortex (Dzhala et al., 2005). The 
late postnatal expression of another key 
GABAergic protein, the GABA-
synthesizing enzyme glutamic acid 
decarboxylase (GAD65 and GAD67), 
has been suggested to contribute to the 
susceptibility of the neonatal brain to 
perinatal hypoxia-ischemia (Xu et al., 
2011). Further translational work on this 
topic is obviously needed. 
 
Influence of activity on KCC2  
up-regulation 
Studies on the effects of chronic block-
ade of glutamatergic signaling and action 
potentials in cultured hippocampal neu-
rons suggest that endogenous ionotropic 
glutamatergic signaling and even the 
firing of spikes are not needed for the 
developmental induction of KCC2 
mRNA or protein (Ganguly et al., 2001; 
Ludwig et al., 2003). The requirement of 
signals mediated by GABAARs for up-
regulation of KCC2 has been subject to 
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dispute. While Ganguly et al. (2001) 
reported a significant reduction of KCC2 
mRNA by ~25% at DIV9 and by ~70% 
at DIV12-15 following GABAAR block-
ade starting at DIV3 (see also Leitch et 
al., 2005), a study by Ludwig et al. 
(2003) did not observe any effect on 
KCC2 protein levels when GABAARs 
were blocked from DIV2 to DIV15. In 
support of the latter observation, chronic 
blockade of GABAARs failed to prevent 
the developmental hyperpolarizing 
EGABA-A shift of cultured midbrain neu-
rons (Titz et al., 2003). Furthermore, 
KCC2 mRNA and protein levels remain 
unperturbed despite the lack of depolar-
izing GABAergic signaling (Pfeffer et 
al., 2009; Sipilä et al., 2009) and even in 
complete absence of GABAergic synap-
tic transmission (Wojcik et al., 2006), as 
seen in mice lacking NKCC1 or the 
vesicular inhibitory amino acid trans-
porter (VIAAT), respectively. In contrast 
to blockade of endogenous glutamatergic 
and GABAergic signaling, the effects of 
the glutamatergic proconvulsant kainate 
suggest that increased neuronal activity 
associated with pathophysiological 
insults may have pronounced effects on 
the developmental expression of KCC2 
(Galanopoulou, 2008; Briggs and 
Galanopoulou, 2011).  
Chronic treatment of neonatal rats 
with nicotine has been reported to in-
crease hippocampal expression of KCC2 
and BDNF mRNA (Damborsky and 
Winzer-Serhan, 2012). This is an intri-
guing observation, as impaired up-
regulation of KCC2 protein was reported 
in the hippocampi of KO mice deficient 
for the ?7 subunit of the nicotinic acetyl-
choline  receptor  (nAChR)  (Liu  et  al.,  
2006). However, whether there is a 
potential role for BDNF in this case is 
unclear as BDNF has been demonstrated 
to inhibit functional activation of nA-
ChRs containing the ?7 subunit 
(Fernandes et al., 2008). Moreover, in 
view of the neurotrophin hypothesis of 
BDNF as an instructive signal for the 
developmental up-regulation of KCC2 
(Aguado et al., 2003; Carmona et al., 
2006; Ludwig et al., 2011b), it is intri-
guing that general anesthetics, which are 
powerful modulators of not only GA-
BAergic and glutamatergic activity 
(Rudolph and Antkowiak, 2004), but 
also  of  the  BDNF-TrkB  signaling  path-
way (Lu et al., 2006; Ponten et al., 2011; 
Popic et al., 2012), appear not to have 
any effect on the progression of up-
regulation of the total KCC2 protein 
level during the brain growth spurt 
(Lacoh et al., 2013). However, it is of 
interest to note here that striking modu-
latory effects of these agents have been 
demonstrated on the development of 
spine  density  (De et  al.,  2009;  Briner  et  
al., 2010; 2011).  
 
Subcellular distribution of KCC2 in 
pyramidal neurons 
In hippocampal and neocortical pyrami-
dal neurons, KCC2 is associated with the 
plasma membrane and transport vesicle 
membranes of somato-dendritic com-
partments  (Gulyas  et  al.,  2001;  Baldi  et  
al., 2010; Kovacs et al., 2013), including 
dendritic spines (Gulyas et al., 2001; 
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Baldi et al., 2010; Gauvain et al., 2011; 
Kovacs et al., 2013). It is absent from the 
axonal compartments, including the axon 
terminals and the initial segment 
(Szabadics  et  al.,  2006;  Baldi  et  al.,  
2010; see also Williams et al., 1999; 
Hübner et al., 2001; Bartho et al., 2004).  
A somato-dendritic KCC2 concentration 
gradient, with relatively higher expres-
sion of immunogold-labeled KCC2 in 
the apical dendritic membrane and cyto-
plasm, was observed in dentate granule 
cells (DGCs) and CA1 pyramidal neu-
rons of the rat hippocampus (Baldi et al., 
2010; see also Bartho et al., 2004). A 
similar, dendritically declining, native 
somato-dendritic gradient of EGABA-A, 
reflecting an uneven distribution of 
functionally active KCC2 along the cell 
membrane, has been reported using 
gramicidin-patch recordings in adult 
mouse  DGCs  and  rat  CA1  pyramidal  
neurons (Khirug et al., 2008). Along the 
apical dendrite itself KCC2 appears 
evenly distributed in DGCs (Baldi et al., 
2010), but in CA1 pyramidal neurons the 
highest KCC2 membrane densities have 
been observed in the proximal part of 
stratum radiatum and in the stratum 
lacunosum moleculare, i.e. the dendritic 
parts  which  are  closest  and  the  furthest  
away from the soma (Gulyas et al., 2001; 
Baldi et al., 2010). Although no detailed 
comparative somato-dendritic distribu-
tion analysis has been published for 
cortical pyramidal neurons, the strong 
dendritic versus somatic KCC2 labeling 
in all cortical layers (Kovacs et al., 2013) 
and the robust somato-dendritic EGABA-A 
gradient recorded in cortical layer 2/3 
pyramidal neurons (Khirug et al., 2008) 
suggest that a somato-dendritic KCC2-
density gradient is a feature of both 
hippocampal and neocortical principal 
neurons. 
Considerable developmental and 
regional variations in the distribution of 
KCC2 between the membrane and cyto-
solic compartments have been observed. 
A gradual decrease in cytoplasmic 
transport vesicle-associated KCC2 paral-
leled by an increase in plasma mem-
brane-bound KCC2 was reported using 
immunogold-labeling during early post-
natal development in rat hippocampal 
principal cells (Gulyas et al., 2001; see 
also Zhang et al., 2006). However, no 
such effect was seen in either the ento-
rhinal or the somatosensory cortex 
(Kovacs et al., 2013; see also Vale et al., 
2005; Blaesse et al., 2006). On the con-
trary, the authors reported an increase in 
association of KCC2 with transport 
vesicles from ~20% of total immuno-
gold-labeled KCC2, at P2, to ~40-50% 
by P12 in superficial cortical layers 
(Kovacs et al., 2013). Moreover, in deep 
layers of these cortical regions, more 
than half of all KCC2 was associated 
with transport vesicles at all postnatal 
ages studied. A recent study, implement-
ing trypsin-mediated enzymatic ‘shav-
ing’ of the cell surface for quantitative 
analysis of surface-expressed proteins 
(Tjalsma et al., 2008), reported that only 
~20% of the total KCC2 protein in the 
P19-22 rat hippocampus is expressed in 
the plasma membrane (Ahmad et al., 
2011). As this approach is, by definition, 
able to detect only proteins that are 
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integrated in the plasma membrane, it 
avoids overestimation of membrane 
expression inherent to immunocyto-
chemical approaches, where proteins 
located near the membrane may be 
erroneously interpreted as surface-
expressed. This notion is especially 
relevant in the case of KCC2, as the 
commonly used antibodies are directed 
against either epitopes in the C- or 
N-termini (Blaesse et al., 2006; Chamma 
et al., 2012), both of which are cytosolic 
(see above).  
Studies on the ultrastructural local-
ization of KCC2 in principal neurons 
suggest also differential expression 
profiles of KCC2 in spines of cortical 
and hippocampal neurons. Quantifica-
tion of the spine plasma membrane-
associated KCC2 in adult rat CA1 py-
ramidal cells from adult rats has been 
estimated as ~40% of that labeled by 
immunogold in the shaft membrane 
(Baldi et al., 2010). In mature cultured 
hippocampal neurons, the intensity of 
KCC2 immunostaining was reported as 
~76% higher in spines compared to 
dendritic shafts, and as three-fold higher 
than that in the cytoplasm (Gauvain et 
al., 2011; see also Chamma et al., 2012). 
In contrast, according to a recent study, 
by P12 only ~10% and ~15% of the total 
KCC2 immunogold particles in a given 
neuron appear to be associated with 
spines in the rat superficial somatosenso-
ry and entorhinal cortices, respectively 
(Kovacs  et  al.,  2013).  Moreover,  in  the  
rat hippocampus, robust KCC2 expres-
sion  within  both  the  necks  and  heads  of  
spines  was  demonstrated  (Gulyas  et  al.,  
2001; Gauvain et al., 2011), and in corti-
cal neurons KCC2 was observed to 
preferentially localize near the spine 
neck or even to the spine apparatus, but 
not to spine heads (Kovacs et al., 2013). 
The spine apparatus, which is found in a 
fraction of spines, consists of specialized 
smooth endoplasmic reticulum (ER), and 
because spines are not typically associat-
ed with rough ER (Yuste, 2010), a re-
quirement for the production of mem-
brane proteins, the reported localization 
of KCC2 to this structure is intriguing 
but warrants confirmation. 
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2.3.3 REGULATION OF KCC2 
Transcriptional regulation of KCC2 
expression 
Unlike other mammalian KCCs, which 
are expressed widely or even ubiquitous-
ly  (Becker  et  al.,  2003;  Arroyo  et  al.,  
2013) the expression of both KCC2 
splice variants is largely restricted to 
central neurons with negligible expres-
sion in peripheral neurons and non-
neuronal cells (Payne et al., 1996; Rivera 
et al., 1999; Williams et al., 1999; Song 
et al., 2002; Stein et al., 2004; Uvarov et 
al., 2007; 2009; Uvarov, 2010). Howev-
er, the mechanisms responsible for driv-
ing expression of KCC2 in central neu-
rons but not in other cells of the body are 
not clear-cut. Since the fairly recent 
discovery of the KCC2a isoform 
(Uvarov et al., 2007), no studies have yet 
addressed the mechanisms behind the 
confinement of its expression to neurons. 
Interestingly, KCC2a expression was 
recently reported also in avian cardio-
myocytes (Antrobus et al., 2012), sug-
gesting profound differences in tran-
scriptional regulation between the two 
KCC2 splice variants.  
For KCC2b, a potential neuron-
restricting mechanism emerged after a 
consensus sequence for the neuron-
restrictive silencer element (NRSE aka 
RE1) was identified in intron 1b of the 
genes coding for KCC2 in mouse and 
human (Fig. 3; Karadsheh and Delpire, 
2001; Song et al., 2002). Binding of the 
neuron-restrictive silencing factor 
(NRSF  aka  REST)  to  NRSE  has  been  
shown to repress the expression of mul-
tiple neuron-specific genes in non-
neuronal cells (Chong et al., 1995; 
Schoenherr and Anderson, 1995). 
Karadsheh and Delpire (2001) were the 
first to propose that NRSE-NRSF-
mediated repression of transcription of 
the gene encoding for KCC2 in non-
neuronal cells might underlie the neuron-
restricted expression profile of KCC2. 
However, this view was challenged by 
Uvarov et al. (2005) using transgenic 
mice  with  a  deletion  of  the  NRSE  se-
quence in a KCC2 reporter gene. While 
exogenous  NRSF  was  able  to  down-
regulate reporter KCC2 activity, it failed 
to derepress non-neuronal KCC2 expres-
sion. Interestingly, another NRSE site, 
located upstream from the transcription 
start site on the KCC2 gene was reported 
more  recently  (Yeo  et  al.,  2009).  It  is  
thus possible that redundancy in the 
transcriptional machinery regulating 
KCC2 gene repression in non-neuronal 
cells accounts for the absence of dere-
pression after deletion of only one NRSE 
site in the gene coding for KCC2. To 
substantiate this, studies on the effects of 
a dual NRSE deletion are needed.  
A 1.4 kb promoter fragment up-
stream from the transcription start site of 
the KCC2 gene has been demonstrated 
sufficient to mediate neuron-specific 
KCC2 expression (Uvarov et al., 2005). 
This evolutionarily conserved promoter 
area was found to contain multiple tran-
scription factor (TF) binding sites, in-
cluding  that  for  the  TF  early  growth  
response  4  (EGR4  aka  NGFI-C)  of  the  
EGR  family  of  zinc  finger  TFs  (Fig.  3;  
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Uvarov et al., 2006), whose expression 
can be induced by neurotrophins and 
neuronal activity (O'Donovan et al., 
1999).  
Of the neurotrophins, signaling 
mediated in particular by the brain-
derived neurotrophic factor (BDNF) and 
its receptor tropomyosin-related kinase 
B (TrkB) (Park and Poo, 2013) has been 
suggested to play a role in the develop-
mental up-regulation of KCC2 mRNA 
(Aguado et al., 2003; Carmona et al., 
2006; Ludwig et al., 2011a; 2011b). 
Embryonic over-expression of BDNF 
(Aguado et al., 2003) and genetic dele-
tion of TrkB (Carmona et al., 2006) were 
reported to increase and decrease, re-
spectively, KCC2 mRNA levels. How-
ever, absence of TrkB signaling did not 
result in apparent impairment of the 
developmental shift in GABAergic 
action (Carmona et al., 2006). The simi-
larity between KCC2 and EGR4 with 
respect to the developmental and neuron-
specific expression patterns in the rat 
brain (Crosby et al., 1992; Uvarov et al., 
2006), prompted the hypothesis that 
neuron-specific developmental up-
regulation of KCC2 is driven via neuro-
trophin-induced expression of the tran-
scription factor EGR4 (Uvarov et al., 
2006; Ludwig et al., 2011a; 2011b). 
Application  of  BDNF  or  of  neurturin,  a  
member of the glial cell-derived neu-
rotrophic factor family (Airaksinen and 
Saarma, 2002), to immature cultured 
hippocampal neurons was shown to 
induce extracellular signal-regulated 
kinase 1/2 (ERK1/2)-dependent expres-
sion  of  EGR4  and  activation  of  the  
KCC2b promoter and to significantly 
increase the expression of KCC2 mRNA 
and protein (Ludwig et al., 2011a; 
2011b). Also, injections of neurturin into 
hippocampi  of  rats  at  P5  led  to  an  in-
crease, albeit modest, in KCC2 im-
munostaining at P8 (Ludwig et al., 
2011a). The effect of exogenous BDNF 
application was prevented by mutating 
the  EGR4  site  in  the  KCC2  promoter,  
rendering it unable to bind endogenous 
EGR4 (Ludwig et al., 2011b). Mutating 
the EGR4 binding site, knockdown of 
EGR4, or expression of a dominant 
negative EGR4 isoform resulted in ~25-
50% decrease in KCC2 expression in 
neuroblastoma and dissociated cortical 
cultures (Uvarov et al., 2006). However, 
as only maximum of ~50% of total 
KCC2 expression was down-regulated 
under various conditions of diminished 
EGR4 signaling (Uvarov et al., 2006), 
transcriptional regulation of KCC2 
expression is likely to be under control 
of additional transcription factors, e.g. 
upstream stimulating factors USF1-2 (cf. 
Markkanen et al., 2008). Up-regulation 
of KCC2 through developmental down-
regulation microRNA-92 has been also 
suggested (Barbato et al., 2010). Of the 
EGR family members (EGR1-4) ex-
pressed during human brain develop-
ment, the transcript expression especial-
ly  of  EGR1  robustly  follows  that  of  
KCC2 (Kang et al., 2011; 
http://hbatlas.org/hbtd/images/wholeBrai
n/EGR1.pdf), while expression of EGR4 
is up-regulated much less (Kang et al., 
2011; http://hbatlas.org/hbtd/images/who
leBrain/EGR4.pdf). This suggests that, 
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unlike in the rat (Crosby et al., 1992; 
Uvarov  et  al.,  2006),  in  humans,  EGRs  
other than EGR4 may be important for 
up-regulation of KCC2 expression dur-
ing brain development.  
Taken together, neuron-specific 
expression of KCC2b during develop-
ment is unlikely to rely on a single tran-
scriptional mechanism. A redundancy in 
transcriptional regulation of KCC2 
might serve the purpose of minimizing 
perturbations in KCC2 expression, 
which, as exemplified by constitutive 
KO (KCC2a and KCC2b; Hübner et  al.,  
2001b; KCC2b; Woo et al., 2002; see 
also Khalilov et al., 2011) or over-
expression (Reynolds et al., 2008; Horn 
et al., 2010) of KCC2, can have devas-
tating effects on CNS development and 
perinatal survival.  
 
Post-translational regulation of KCC2  
Post-translational modifications of the 
KCC2 protein have been suggested to 
regulate its functional expression in 
developing and mature neurons. For 
example, work on the developing brain-
stem has demonstrated that despite 
similarly high expression levels of 
KCC2 protein in the early postnatal 
period and by the second month of life in 
the lateral superior olive (LSO; 
Balakrishnan et al., 2003; Blaesse et al., 
2006) and the cochlear nucleus (Vale et 
al., 2005), the Cl- extrusion capacity of 
LSO neurons emerges gradually during 
the first weeks of life (Balakrishnan et 
al., 2003; Blaesse et al., 2006). Likewise, 
in the retina KCC2 is expressed but 
largely localized in the cytosol of gan-
glion cells during the first two postnatal 
weeks and appears at or near the plasma 
membrane only by the third week 
(Zhang et al., 2006). Studies on imma-
ture cultured hippocampal neurons have 
shown  that  a  considerable  pool  of  
transport active KCC2 can be recruited 
within minutes using broad-spectrum 
kinase inhibitors (Kelsch et al., 2001; 
Khirug et al., 2005). Examples of this 
kind suggest that the mere presence of 
KCC2 protein, even at high levels, does 
not automatically endow a neuron with 
efficient Cl- extrusion. Thus, post-
translational modifications are likely to 
be important in determining the overall 
kinetics of KCC2-mediated K-Cl cotran-
sport by regulation of the intrinsic ion 
transport rates and/or the number of 
plasmalemmal KCC2 molecules 
(Blaesse et al., 2009).  
Work by Kelsch et al. (2001) on 
cultured hippocampal neurons from rat 
first suggested that a kinetic activation of 
KCC2 by tyrosine phosphorylation is 
required for the increase in neuronal Cl- 
extrusion capacity during development 
(see also Khirug et al., 2005). Along 
similar lines, later work by Stein and 
colleagues (2004), utilizing a pan-
phosphotyrosine antibody, demonstrated 
that the amount of tyrosine-
phosphorylated KCC2 increased in the 
mouse cortex between P3 and P30 (Stein 
et al., 2004). Vale et al. (2005) observed 
that KCC2 protein was highly expressed 
in both P1 and P40 neurons of the coch-
lear nucleus (see also Balakrishnan et al., 
2003; Blaesse et al., 2006), whereas the 
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level of tyrosine-phosphorylated KCC2 
was virtually absent at birth and became 
significantly  higher  at  P40  (Vale  et  al.,  
2005). Conversely, threonine residues 
906 and 1007 of KCC2 appear to be 
partially phosphorylated in neonatal 
mouse brain and dephosphorylated in 
parallel with brain maturation (Rinehart 
et al., 2009). A simultaneous substitution 
of both of these residues to non-
phosphorylatable alanines leads to robust 
activation of KCC2, as seen in HEK-293 
cells (Rinehart et al., 2009).  
Glycosylation is an important fac-
tor  in  regulation  of  protein  folding,  cell  
surface expression, and function of 
membrane-expressed glycoproteins 
(Rasmussen, 1992; Roth, 2002). Alt-
hough extracellular N-linked glycosyla-
tion has been shown to play a decisive 
role in the membrane expression and 
function of KCC3 (Ding et al., 2013), 
KCC4 (Weng et al., 2013) and NKCC1 
(Ye et  al.,  2012),  no data exist  to estab-
lish  whether  this  type  of  post-
translational modification is necessary 
for KCC2 functions. Nonetheless, a 
glycosylation pattern of KCC2 of the 
kind observed in mature neurons does 
not appear to be alone sufficient for the 
induction of ion transporter activity 
(Blaesse et al., 2006; see also Hartmann 
et al., 2009).  
Clustering  of  KCC2  in  the  cell  
membrane (Watanabe et al., 2009; 
Hartmann  et  al.,  2009;  Gauvain  et  al.,  
2011; Nardou et al., 2011b) has been 
suggested to involve KCC2 oligomeriza-
tion and to regulate its membrane stabil-
ity,  activity,  or  both  (Watanabe  et  al.,  
2009; Chamma et al., 2012; see also 
Blaesse  et  al.,  2006;  Hartmann  et  al.,  
2009; Uvarov et al., 2009). KCC2 clus-
ters appear to be modulated by phos-
phorylation mechanisms as loss of 
KCC2 tyrosine phosphorylation was 
associated with a more diffuse mem-
brane expression pattern and with shift 
in  EGABA-A towards more depolarized 
values (Watanabe et al., 2009). Intri-
guingly, KCC2 clustering was also 
reported to correlate with the maturation 
of dendritic spines, with maximal KCC2 
clustering observed in mushroom-type 
spines, intermediate levels in stubby 
spines and low or no clustering in non-
functional filopodia-like dendritic pro-
trusions (Chamma et al., 2012). The 
main scaffolding protein of GABAergic 
synapses, gephyrin, forms clusters that 
are sensitive to (i) phosphorylation state 
of gephyrin and (ii) to the activity-
dependent cleavage of gephyrin by the 
Ca2+-dependent protease calpain 
(Tyagarajan et al., 2011; Tyagarajan et 
al., 2013). While gephyrin has been 
demonstrated to colocalize or juxtapose 
with KCC2 in hippocampal and spinal 
cord neurons (Hübner et al., 2001b; 
Chamma  et  al.,  2012),  further  work  is  
needed to assess whether KCC2 clusters 
functionally associate or are coregulated 
with gephyrin clusters. Important ques-
tions regarding KCC2 clustering are 
whether such clusters are modulated by 
neuronal activity e.g. via calpain cleav-
age, and whether KCC2 clustering re-
quires an interaction of the CTD KCC2 
with  the  cytoskeleton  (cf.  Li  et  al.,  
2007). Deletion of the last 28 amino 
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acids of the C-terminus (KCC2-?1089-
1116) results in a membrane-expressed 
KCC2 protein that does not form clusters 
(Watanabe et al., 2009). The region 929-
1043  of  the  KCC2  CTD,  which  is  re-
quired for KCC2 activity under isotonic 
conditions, also encompasses two pre-
dicted PEST sequences which, among 
the KCCs, are completely unique to 
KCC2 (Mercado et al., 2006). This is 
interesting, because PEST domains can 
serve to target proteins for calpain-
dependent degradation (Rechsteiner and 
Rogers, 1996; Wang et al., 2003; but see 
Carillo et al., 1996), although calpain-
mediated cleavage of KCC2 has been 
also speculated to result in functional 
activation of the cotransporter (Mercado 
et al., 2004).  
There is indication for a very high 
rate of turnover,  i.e.  recycling, of KCC2 
at the cell membrane (Lee et al., 2007), 
suggesting that the transporter is subject 
to continuous kinetic modulation 
(Blaesse et al., 2009). While the surface 
half-life of, for instance, GABAAR 
subunits is greater than 30 minutes 
(Thomas  et  al.,  2005),  the  half-life  of  
membrane-associated KCC2 appears to 
be strikingly fast at ~5 minutes, as seen 
in HEK-293 cells (Lee et al., 2007). The 
work by Lee et al. (2007; 2011) identi-
fied serine 940 (S940) located in the 
C-terminal domain of KCC2 as the main 
site of direct phosphorylation of KCC2 
by protein kinase C (PKC). Using HEK-
293 cells, the authors further demon-
strated that activation of PKC increases 
KCC2 cell surface stability and ion 
transport activity (Lee et al., 2007). 
Analysis of endogenous KCC2 ex-
pressed in cultured rat hippocampal 
neurons revealed a striking ~300% 
increase in KCC2 phosphorylation and 
surface expression within 10 minutes of 
PKC activation, while inhibition of PKC 
under basal conditions robustly de-
creased KCC2 phosphorylation (Lee et 
al., 2007). In support of that rapid 
changes in KCC2 membrane expression 
mediated by mechanisms regulating 
membrane trafficking, blocking clathrin-
dependent endocytosis, was reported to 
elevate the cell surface levels of KCC2 
to ~275% of control values within 45 
minutes (Lee et al., 2010; see also Zhao 
et al., 2008). Such rapid 
(de)phosphorylation-controlled mem-
brane recycling of KCC2 is likely to 
permit dynamic post-translational regu-
lation  of  the  relative  amount  and  the  
intrinsic functional properties of KCC2 
molecules located in the plasma mem-
brane and cytosolic vesicles. As a strik-
ing example of this, elevation of gluta-
mate levels in dissociated hippocampal 
neuronal cultures was demonstrated to 
trigger, through activation of NMDARs, 
Ca2+ and protein phosphatase 1 (PP1)-
dependent dephosphorylation of KCC2 
at S940, resulting in robust down-
regulation of total and membrane-
associated KCC2 as well as loss of 
hyperpolarizing GABAA responses (Lee 
et al., 2011; see also Sarkar et al., 2011). 
How dephosphorylation of S940 leads to 
degradation of KCC2 protein was not 
demonstrated. Curiously, as seen in 
cultured hippocampal neurons, the tyro-
sine phosphatase inhibitor sodium per-
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vanadate was shown to trigger down-
regulation of both the total and surface-
expressed KCC2 in a manner that was 
sensitive to the broad-spectrum protease 
inhibitor leupeptin, which was used at a 
high concentration of 200 µg/ml 
(~470 µM; Lee et al., 2010). In spite of 
the fact that leupeptin is a well-known 
inhibitor of a number of lysosomal and 
extra-lysosomal proteases, including the 
Ca2+-activated calpain (Goll et al., 
2003), the authors concluded that the 
lysosomal pathway was responsible for 
down-regulation of KCC2 under the 
pertinent conditions (Lee et al., 2010). It 
should be noted that leupeptin at high 
concentrations has been reported to 
paradoxically result in stimulation of 
proteolytic activity (Sutherland and 
Greenbaum, 1983), which further com-
plicates the interpretation of the results 
obtained under the experimental condi-
tions employed by Lee et al. (2010).  
With regard to the post-
translational regulation of the structural 
role of KCC2, only the protein-protein 
interaction between the CTD of KCC2 
and the FERM domain of protein 4.1N 
has been implicated (Li et al., 2007; 
Horn et al., 2010). Although NL-2, a 
postsynaptic adhesion molecule previ-
ously implicated in the regulation of 
GABAergic synaptogenesis (Chih et al., 
2005), has been recently suggested to 
play regulatory role over the structural 
function of KCC2 in spine formation 
(see above), the lack of co-
immunoprecipitation of KCC2 with 
NL-2 suggests that this interaction may 
be indirect (Sun et al., 2013). 
2.3.4 THE ROLE OF KCC2 IN 
CNS PATHOLOGY  
In the mature rodent CNS, depolarizing 
GABAAR-mediated responses are often 
seen under pathological conditions asso-
ciated with enhanced neuronal excitation 
(Cohen et al., 2002; Miles et al., 2012). 
Deficits in KCC2 expression, often 
associated with decreased efficacy of 
GABAergic inhibition and emergence of 
depolarizing GABAAR-mediated cur-
rents that reflect decreased neuronal Cl- 
extrusion, have been documented fol-
lowing experimental seizures (Rivera et 
al., 2002; Pathak et al., 2007; Li et al., 
2008; Lee et al., 2010; Barmashenko et 
al., 2011; Shin et al., 2012; Reid et al., 
2013), in models of cerebral ischemia 
(Papp et al., 2008; Jaenisch et al., 2010; 
Mao et al., 2012; Dai et al., 2013), trau-
matic brain injury (Jin et al., 2005; 
Bonislawski et al., 2007), and neuro-
pathic pain following spinal cord injury 
or nerve ligation (Coull et al., 2003; Lu 
et al., 2008; Miletic and Miletic, 2008; 
Boulenguez et al., 2010; Janssen et al., 
2012; Zhou et al., 2012). The clinical 
relevance of changes in KCC2 expres-
sion is also highlighted by reports of 
decreased levels of KCC2 protein and 
loss of hyperpolarizing GABAAR-
mediated signaling in resected epileptic 
tissue from human patients with tem-
poral lobe epilepsy (TLE; Palma et al., 
2006; Huberfeld et al., 2007; Munoz et 
al., 2007; see also Cohen et al., 2002; 
Deisz 2002). Down-regulation of KCC2 
and up-regulation of NKCC1 has been 
implicated in generation of spontaneous 
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interictal-like activity (i.e. the 
epileptiform activity occurring between 
seizures; Huberfeld et al., 2007; Miles et 
al., 2012). 
Under these diverse traumatic situ-
ations, KCC2 down-regulation may be 
related to activation of the TrkB receptor 
by BDNF (Rivera et al., 2002; Rivera et 
al., 2004; Coull et al., 2005; Wake et al., 
2007; Shulga et al., 2008). Exogenously 
applied BDNF was shown to down-
regulate KCC2 via TrkB receptors in 
cultured hippocampal neurons (Rivera et 
al., 2002; Wake et al., 2007). Similarly, 
following epileptiform activity induced 
by withdrawal of extracellular Mg2+, the 
efficacy of Cl- extrusion was reduced in 
a BDNF-dependent manner within a few 
hours in parallel with KCC2 down-
regulation of KCC2 mRNA and protein 
(Rivera et al., 2004; see also Wake et al., 
2007). The authors concluded that this 
effect was attributable to transcriptional 
changes in KCC2 expression levels 
(Rivera et al., 2004). However, the pos-
sibility that the decreased efficacy of Cl- 
extrusion was caused by changes in post-
transcriptional mechanisms could not be 
excluded. Indeed, a study by Wardle and 
Poo (2003) suggests that BDNF can act 
on KCC2 function within a time window 
that is too rapid to be mediated by tran-
scriptional effects. Experiments with 
animals expressing loss of signaling 
point mutations in the TrkB receptor 
demonstrated that both the Shc (src 
homology 2 domain containing trans-
forming protein) and PLC?-CREB 
(phospholipase C?-cAMP response 
element-binding) pathways must be 
activated to induce down-regulation of 
KCC2 protein by BDNF or 0-Mg2+ 
(Rivera et al., 2004). Notably, activation 
of the PLC? pathway is known to trigger 
elevations in [Ca2+]i (Berridge et al., 
2000), a necessary condition for rapid 
down-regulation of KCC2 following 
intense glutamatergic stimulation 
(Fiumelli et al., 2005; Lee et al., 2011). 
In contrast, the activation of the Shc 
pathway alone via the TrkB receptor 
enhances KCC2 synthesis under these 
conditions (Rivera et al., 2004). The 
above findings by Rivera et al. (2004) 
point to divergence in the actions of 
BDNF on regulation of KCC2 via down-
stream signaling of the TrkB receptor. 
Thus, the explanation for how BDNF 
exerts opposite effects on KCC2 in 
immature (Aguado et al., 2003; Ludwig 
et al., 2011) and mature (Rivera et al., 
2002; 2004; Coull et al., 2005; Wake et 
al., 2007; Miletic and Miletic, 2008), or 
in intact and damaged neurons (Shulga 
et al., 2008; see also Shulga et al., 2009) 
may lie within the regulation of molecu-
lar cascades down-stream of TrkB.  
Knock-down of KCC2 was report-
ed to decrease the resistance of cultured 
neurons to NMDA-toxicity, whereas 
overexpression of KCC2 to protect from 
cell death (Pellegrino et al., 2011). This 
effect was attributed to K-Cl cotransport 
function of KCC2, as also over-
expression of KCC3, a KCC isoform that 
does not maintain spines, had a compa-
rable rescuing effect. Moreover, overex-
pression of the transport-inactive KCC2-
Y1087D mutant failed to ameliorate cell 
death (Pellegrino et al., 2011).  
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It has been suggested (Huberfeld et al., 
2007; Miles et al., 2012) that down-
regulation of KCC2 leads to a decrease 
in the metabolic costs of maintaining 
cation gradients thereby reflecting an 
adaptive response to the “energy crisis” 
(cf. Hansen, 1985) commonly 
accompanying ischemia and seizure 
activity (Aiyathurai and Boon, 1989; 
Berger and Garnier, 1999; Kovac et al., 
2012). Such a teleological explanation is 
probably also valid for the down-
regulation of the Na-K ATPase (cf. 
Pylova  et  al.,  1989;  Anderson  et  al.,  
1994; Fernandes et al., 1996). 
Accordingly, work performed on an in in 
vitro model of CNS ischemia has shown 
that the robust loss of ATP followed by 
partial recovery during a 3 hour-long 
reoxygenation period could be 
completely recovered using either 
bumetanide or furosemide at 
concentrations which inhibit both 
NKCC1 and KCC2 (Pond et al., 2004).  
 
KCC2 in neonatal seizures 
Most commonly caused by hypoxic 
ischemic encephalopathy, hemorrhage, 
or cerebral infarction, seizures affect 
~2% of neonates in intensive care units 
in Western societies (Bartha et al., 2007; 
Jensen, 2009; Seshia et al., 2011). 
Neonatal seizures portend severe 
neurological dysfunction later in life, 
with survivors experiencing higher rates 
of epilepsy (Ronen et al., 2007; Pisani et 
al., 2012) and motor and cognitive 
deficits (McBride et al., 2000; Tekgul et 
al., 2006; Ronen et al., 2007; Painter et 
al., 2012). Rodent models have revealed 
that seizures early in development alter 
synaptic organization and plasticity, and 
prime cortical neurons to increased 
seizure-susceptibility later in life (Ben-
Ari and Holmes, 2006; Rakhade et al., 
2011). Therefore, prompt diagnosis and 
successful treatment of seizures in 
neonates is necessary for improving 
long-term neurologic outcomes.  
Standard antiepileptic drugs 
(AEDs), such as phenobarbital and 
benzodiazepines, which enhance 
GABAergic transmission by directly 
targeting GABAARs, are less effective in 
suppressing seizures in neonates than in 
adults  (Painter  et  al.,  1999;  Booth  and  
Evans, 2004). This is not surprising, 
because the signaling mechanisms and 
pharmacological properties of neurons in 
the immature brain are different from 
those  in  the  adult  (Clancy  et  al.,  2001;  
Avishai-Eliner et al., 2002; Erecinska et 
al., 2004a). The idea to use bumetanide 
with  the  aim  to  block  NKCC1  and  
thereby to enhance the efficacy of AEDs 
acting via GABAARs, has gained 
conciderable attention (Dzhala et al., 
2005; 2008; 2010; Kilb et al., 2007; 
Rheims et al., 2008; Mares, 2009; 
Mazarati et al., 2009; Kahle et al., 2009; 
Nardou et al., 2009; 2011; Minlebaev 
and Khazipov, 2011; Wahab et al., 2011; 
Cleary et al., 2013; Vargas et al., 2013). 
While this is a prevalent hypothesis in 
the context of Cl- regulation in neonatal 
seizures (for review, see Briggs and 
Galanopoulou, 2011; Ben-Ari et al., 
2012; Löscher et al., 2013; Pressler and 
Mangum, 2013), the possible changes in 
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the functional expression of KCC2 have 
been adressed, surprisingly, by only a 
few studies (Galanopoulou, 2008; 
Nardou et al., 2011b).  
Working on an in vitro preparation 
composed of two intact interconnected 
P7-8 rat hippocampi perfused in a 
tripartite chamber, Nardou et al. (2009) 
reported that inhibition of NKCC1 with 
bumetanide did not prevent generation of 
kainate-induced seizures or propagation 
of seizures to the contralateral “drug 
naive” hippocampus. NKCC1 inhibition 
also failed to prevent the formation of an 
acute epileptogenic mirror focus in the 
contralateral hippocampus that had not 
been exposed to propagating seizures 
originating from the kainate-exposed 
hippocampus (Nardou et al., 2009). In 
subsequent studies, Nardou et al. 
(Nardou et al., 2011a; 2011b) 
demonstrated that the AED 
phenobarbital, which prolonges the 
open-time  of  GABAARs, when applied 
to the contralateral hippocampus at the 
onset of propagating seizures, reduced 
the interictal-like events and prevented 
the formation of an epileptogenic focus. 
These results suggest that during the 
initial few seizure events, GABAergic 
signaling is efficient enough to prevent 
epileptogenesis in the rodent 
hippocampus already by the end of the 
first postnatal week, despite the still 
relatively immature level of Cl- extrusion 
capacity at this age (Khirug et al., 2005; 
Tyzio et al., 2007; 2008). In the studies 
by Nardou et al. (2011a; 2011b), 
phenobarbital was rendered seizure-
aggravating after a number of ictal-like 
events due to a progressive increase in 
[Cl-]i. Work by Dzhala et al. (2010) 
suggested that the progressive 
accumulation of Cl- in P5-7 mice results 
from the up-regulation of NKCC1. 
However, Nardou et al. (2011b) showed 
that epileptic mirror foci are formed at 
this age also in NKCC1 KO mice. 
Importantly, the authors also 
demonstrated that seizures eventually 
lead to down-regulation of KCC2 
function that, in the epileptic mirror 
neurons, was paralleled by 
internalization of KCC2 from the cell 
surface into the cytosol (Nardou et al., 
2011b).  
Three episodes of neonatal 
kainate-induced status epilepticus (3KA-
SE), each elicited at P4-P6, were 
demonstrated to result in a premature 
appearance of hyperpolarizing 
GABAAR-mediated signaling at P9, 
instead of P14 in CA1 pyramidal 
neurons and paralleled by increased 
KCC2 immunoreactivity in the CA1 
region, as observed at P10 
(Galanopoulou, 2008). However, these 
effects were reported to be specific to 
male rats only as similar levels of KCC2 
immunoreactivity were observed in 
female  control  animals  at  P10  as  in  
males who had received three daily 
kainate injections. Moreover, 3KA-SE at 
P4-6 in the female pups was associated 
with a transient depolarizing shift in 
EGABA-A at P8-13 that was attributed to 
increased functional expression of 
NKCC1 during this period 
(Galanopoulou, 2008). In contrast, 
gender-related differences in the effects 
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of the GABAAR agonist isoguvacine 
were observed neither in the 
hippocampal CA3 region, the thalamus, 
nor the amygdala at  P4-6 (Glykys et  al.,  
2009). Regardless, the consequences of 
seizures on the functional expression of 
KCC2 in neonatal rats of either sex in 
the immediate postictal period were  not  
assessed in the study by Galanopoulou 
(2008), where data was collected a 
minumum  of  ~five  days  after  the  first  
seizure episode. Similarly, in the study 
by Nardou et al. (2011b) a minimum of 
5 hours had passed since the first 
kainate-triggered ictal event before 
internalization of KCC2 was assessed 
and  observed.  From  the  stand  point  of  
potential therapeutic interventions 
involving pharmacological modulation 
of KCC2 function, assessment of the 
immediate effect of seizures on KCC2 
expression is of interest.  
 
KCC2 in temporal lobe epilepsy 
Mesial temporal lobe epilepsy (TLE), 
with seizure onset in the structures of the 
medial temporal lobe, notably the hippo-
campus,  is  the  most  common  type  of  
partial epilepsy refractory to AEDs 
(Semah et al., 1998; Tatum, 2012). It is 
also the most commonly occurring type 
of acquired epilepsy in adult humans 
(Semah et al., 1998; Wiebe, 2000; Engel, 
Jr.,  2001).  The causes of TLE are likely 
to be complex and patients often present 
with a precipitating injury, such as birth 
trauma, head injury, febrile seizures, and 
meningitis, typically taking place during 
early childhood (Blumcke et al., 2002). 
A  hallmark  of  TLE  is  sclerosis  of  the  
hippocampus with neuronal loss in the 
regions  of  CA1  and  CA3/4,  but  to  a  
lesser extent in CA2 (Blumcke et al., 
2002). It is, however, unclear whether 
this is a cause or a consequence of sei-
zures (Jefferys, 1999; Blumcke et al., 
2002). It is also far from clear, to which 
extent the processes that contribute to 
epileptogenesis (i.e. the gradual trans-
formation of non-epileptic tissue to one 
spontaneously generating seizures that 
takes place before the first spontaneous 
seizure occurs) overlap with those at 
play during ictogenesis,  the  rapid  pro-
cess of initiation and propagation of a 
seizure in time and space (Pitkänen and 
Lukasiuk, 2011; Löscher et al., 2013). 
For instance, there is some indication 
that the sclerotic loss of hippocampal 
cells may actually hinder epileptogenesis 
(Milward et al., 1999). Thus, an a priori 
interpretation that any observed change 
in the epileptic substrate reflects patho-
logical progression, may lead to failure 
in recognizing intrinsic adaptive pro-
cesses.  
The most effective treatment for 
drug-resistant  TLE  symptoms  to  date  is  
resection of the ictogenic brain regions 
(Engel, Jr., 2001). This has enabled ex 
vivo studies aimed at elucidating the 
mechanisms of seizure generation in 
humans. Such work has demonstrated 
that the in vitro correlates of interictal 
activity may in part be attributable to 
depolarizing GABAAR-mediated signal-
ing of a population of subicular pyrami-
dal neurons downstream of the sclerotic 
CA1 region (Cohen et al., 2002; see also 
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Köhling et al., 1998; Benini et al., 2011). 
This depolarization was later shown to 
be associated with a reduction of KCC2 
expressing cells or down-regulation of 
KCC2 mRNA and protein expression in 
the CA1-subiculum intersection and 
subiculum proper (Huberfeld et al., 
2007; see also Palma et al., 2006; Munoz 
et al., 2007). Interestingly, the observed 
interictal activity was dependent on 
NKCC1  function,  as  inferred  by  its  
sensitivity to low concentrations of 
bumetanide (Huberfeld et al., 2007). 
While increased NKCC1 mRNA in the 
subiculum has been reported (Palma et 
al., 2006), others have observed 
increased NKCC1 immunoreactivity in 
the CA2 region but not in the subiculum 
(Sen et al., 2007). While an acute 
damage-induced depolarizing shift in 
EGABA-A is  likely  to  result  from  post-
translational modification of CCCs and 
down-regulation of the Na-K ATPase, 
the consolidation of this effect may well 
involve long-term genomic regulation of 
KCC2 expression (Löscher et al., 2013). 
From the above studies performed on 
chronically epileptic TLE tissue it is 
impossible to conclude to which extent 
the observed changes in KCC2 
expression are related to the 
epileptogenic or the ictogenic processes, 
and  to  which  extent  they  are  a  result  of  
genomic vs post-translational regulation.  
Rodent models of TLE suggests 
that the time course for significant 
changes in both KCC2 protein and 
mRNA expression levels may under 
certain conditions take place on a 
timescale of few hours. For example, 
following rapid (all stimulations within a 
day) hippocampal kindling, KCC2 
mRNA levels in the mouse dentate gyrus 
(DG) decreased to ~55% by 2 hours and 
to  ~30%  by  6  hours  after  the  last  
stimulation, when also a general 
decrease in KCC2 immunostaining was 
observed  in  the  CA1,  CA3  and  DG  
regions. By 24 hours after kindling, 
partial recovery of KCC2 mRNA and 
immunostaining was observed (Rivera et 
al., 2002). Rapid decrease of total and 
plasmalemmal KCC2 protein in the time 
course of 1-2 hours has been reported in 
the mouse hippocampus following status 
epilepticus (SE) induced by the 
muscarinic acetylcholine receptor 
(mAChR) agonist pilocarpine. This rapid 
effect observed in vivo correlated with 
increased tyrosine phosphorylation and 
was suggested to be induced by 
increased degradation of KCC2 (Lee et 
al., 2010; see also Takkala and Woodin, 
2013). Others using the pilocarpine 
model in rats, have reported decreased 
levels of KCC2 mRNA and protein, 
paralleled by positive EGABA-A shifts in 
the  CA1,  CA3,  DG,  and  the  subiculum  
for up to two weeks post-SE during the 
latent period (Pathak et al., 2007; 
Barmashenko et al., 2011). At least in 
the DG, by the time spontaneous 
seizures begin to appear (2-8 weeks after 
SE), KCC2 total protein levels recover 
and the capacity of DGCs to extrude Cl- 
substantially improves (Pathak et al., 
2007). An important question to be 
adressed by future studies, is whether the 
initial acute loss of DGC dendritic spines 
followed by neo-spinogenesis, which 
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starts approximately two weeks after 
pilocarpine-induced SE (Isokawa, 1998; 
Isokawa, 2000; see also Thind et al., 
2010), involves specific changes in the 
expression of ion transport-independent 
KCC2 functions. It appears that 
expression  of  KCC2  after  SE  displays  
regional variation as, unlike the apparent 
recovery of KCC2 expression in DG 
(Pathak et al., 2007; see also Rivera et 
al., 2002), significantly decreased KCC2 
immunoreactivity in the perirhinal cortex 
is observed upto 4-5 months following 
pilocarpine SE (Benini et al., 2011).  
Disease-associated changes in the 
expression of CCCs leading to 
reemergence of depolarizing or even 
excitatory GABAAR-mediated signaling, 
typical to immature neurons, have been 
proposed to reflect neuronal 
dedifferentiation and ‘recapitulation of a 
developmental programme’ (Cohen et 
al., 2003). Teleologically, this might 
serve the purpose of re-establishing 
plasticity and promote de novo targeting 
of neurons during damage-related 
rewiring (Nabekura et al., 2002; Cohen 
et al., 2003; Payne et al., 2003; Toyoda 
et al., 2003; Rivera et al., 2005). 
Importanly,  the  timing  of  the  critical  
period for plasticity, at least in the visual 
cortex, appears to depend on the level of 
GABAergic activity (Hensch and 
Fagiolini, 2005; Hensch, 2005a; Hensch, 
2005b). In support, intriguing 
correlations between reactivation of 
critical periods for neural plasticity 
(Hensch, 2005a) and decreased levels of 
GABA in the visual cortex (Arckens et 
al., 2000) and of KCC2 protein in the 
CA1 and the basolateral amygdala 
(Karpova et al., 2011) have been 
reported.  
Down-regulation of KCC2 may 
also prevent the generation of the large 
extracellular K+ transients during intense 
activation GABAARs, e.g. during 
seizures or any type of high frequency 
stimulation of neurons, leading to 
substantial electrogenic uptake of Cl- 
driven  by  efflux  of  HCO3- which is 
replenished by carbonic anhydrase-
catalyzed hydration of CO2 (Kaila et al., 
1997; Ruusuvuori and Kaila, 2013). 
Recent work has shown that the HCO3--
driven intraneuronal accumulation of Cl- 
can activate extrusion of Cl- by  KCC2  
(Viitanen et al., 2010), thereby giving 
rise  to  a  K+ efflux that accounts for the 
increase in [K+]o which results in non-
synaptic depolarization of the membrane 
potential. Such a pathophysiological 
increase in [K+]o can lead to a vicious 
cycle comprising a further depolarization 
of both the membrane potential and 
EGABA-A,  and  to  cellular  swelling  that  
enhances proepileptic ephaptic signaling 
(Jefferys, 1995; Somjen, 2002; Miles et 
al., 2012; Löscher et al., 2013). Taken 
together, the above conciderations 
underscore the fact that it is by no means 
a trivial question whether, and when, 
pathophysiological changes in CCC 
expression and function are causes of 
epileptogenesis, or adaptive, seizure 
suppressing consequences of epilepsy.  
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3 AIMS 
 
The major aim of this Thesis was to investigate the effects of glutamatergic signaling on 
KCC2 expression, and vice versa, during brain development. 
 
The specific aims were to:  
 
? Investigate the effects and underlying mechanisms of neonatal seizures on 
KCC2 expression during the immediate postictal period (I and II) 
 
? Identify the proximal mechanisms responsible for rapid down-regulation 
of KCC2 under conditions of enhanced glutamatergic activity (III) 
 
? Assess the functional role of KCC2 in spinogenesis in vivo (IV) 
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Figure  4.  An  electrophysiological  method  to  quantitatively  assess  the  efficacy  of  KCC2-mediated Cl- 
extrusion in pyramidal neurons. A defined Cl- load was imposed via a patch pipette to clamp the somatic 
Cl- concentration ([Cl-])  to  that  of  the  filling  solution  of  the  patch  pipette.  As  a  result  of  net  dendritic  Cl- 
extrusion by KCC2, a declining somato-dendritic [Cl-] gradient is formed from the soma along the dendrite 
(indicated  as  lightening  of  turquoise  from  the  soma  to  the  distal  dendritic  parts).  A  spot  of  UV  light  was  
positioned consecutively at the somatic and the dendritic location for local GABA uncaging to evoke 
GABAAR-mediated currents for determination of their reversal potential in the voltage clamp mode of 
whole-cell patch clamp recordings. Black and white circles indicate the diameters and the relative locations 
of the 10 ms-long uncaging flashes. Dendritic EGABA-A more negative than the somatic EGABA-A indicates the 
presence of an effective Cl- extrusion mechanism and the value of the bumetanide-insensitive difference of 
these, ?EGABA, is taken as a quantitative measure of KCC2-mediated Cl
- extrusion. 
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4 METHODS  
 
For detailed description of the materials and methods used in this Thesis work, the 
reader is referred to the original publications (I-IV). An overview of the methodology is 
provided below: 
The electrophysiological methods comprised visually guided whole-cell, cell-
attached, and field potential recordings in hippocampal and neocortical slices prepared 
acutely from neonatal and juvenile rats and mice. Spike activity of intact single neurons 
was monitored using cell-attached current clamp in the 0-Mg2+ in vitro model of epilep-
tiform activity. Whole-cell voltage clamp was used to study KCC2 functionality under 
conditions of a defined Cl-load imposed via the patch pipette (see Fig. 4). To determine 
EGABA-A,  UV-laser  photolysis  of  caged  GABA was  used  to  evoke  GABAAR-mediated 
currents. Field potential recordings were performed to monitor kainate- and 0-Mg2+-
induced activity in slices. Induction of neonatal seizures in transgenic mice lacking 
BDNF and their WT littermates was done using the proconvulsant kainic acid. Assess-
ment of behavioral seizures was performed using video recordings. Confocal and 
epifluorescence microscopy was used to trace dendrites of dye-filled pyramidal neurons 
and to identify neurons transfected using in utero electroporation. 
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5 RESULTS 
 A SINGLE SEIZURE 5.1
EPISODE LEADS TO RAPID 
FUNCTIONAL ACTIVATION 
OF KCC2 IN THE 
NEONATAL RAT 
HIPPOCAMPUS (I) 
The findings of the present study show 
that immediately following kainate-
induced neonatal SE in P5-7 rats, the 
furosemide-sensitive Cl- extrusion ca-
pacity of CA1 pyramidal neurons is 
significantly enhanced, as seen in ex vivo 
slices following a 1 hour recovery peri-
od. This effect is paralleled by similar 
increases in not only the surface expres-
sion of both of the KCC2a and KCCb 
splice variants but also of the Na-K 
ATPase, which generates the thermody-
namic driving force for K-Cl cotran-
sport. The increase in the Cl- extrusion 
capacity did not correlate with an in-
crease in the total KCC2 protein level, 
indicating that the low level of KCC2 
protein is not a limiting factor for func-
tional activation of KCC2 in hippocam-
pal pyramidal neurons at this age in the 
rodent brain. In corroboration with the 
idea that the functional up-regulation of 
KCC2 is due to kainate-induced increase 
in neuronal activity and not kainate per 
se, a brief application of kainate to naive 
hippocampal slices similarly led to 
enhanced KCC2 function and surface 
expression, but these effects were not 
seen when neuronal activity was blocked 
with TTX. To gain further insight into 
the underlying mechanisms of KCC2 
activation, experiments with the dyna-
min-inhibitory peptide (DIP) demon-
strated that an up-regulation of KCC2 
function similar to that following 
kainate-induced activity could be evoked 
by an acute block of clathrin-dependent 
endocytosis. Both the kainate-induced 
up-regulation of Cl- extrusion and of 
KCC2 surface expression were fully 
blocked by the kinase inhibitor K252a, 
suggesting a potential involvement of the 
Trk family of receptor tyrosine kinases 
in mediating the effect of KCC2 activa-
tion following neonatal seizures. Alt-
hough K252a, a potent non-specific 
inhibitor of Trk kinases (Knusel and 
Hefti, 1992), has been shown to prevent 
TrkB-mediated down-regulation of 
KCC2 (Rivera et al., 2002; 2004), the 
possibility that its effects observed here-
in may be mediated through inhibition of 
other  kinases  than  TrkB,  e.g.  PKC  (cf.  
Kase et al., 1986; Lee et al., 2007), 
cannot be excluded. Thus, further exper-
imental evidence is required to test the 
hypothesis that the functional up-
regulation of KCC2 after neonatal sei-
zures is dependent on BDNF-TrkB 
signaling.   
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 BDNF IS REQUIRED FOR 5.2
ACTIVITY-DEPENDENT BUT 
NOT CONSTITUTIVE UP-
REGULATION OF KCC2 
DURING HIPPOCAMPAL 
DEVELOPMENT (II) 
To investigate the involvement of the 
BDNF-TrkB signaling in the functional 
up-regulation of KCC2 following a 
single neonatal seizure episode, suggest-
ed  by  the  effect  of  the  Trk  inhibitor  
K252a in study I, homozygous BDNF 
KO (BDNF-/-) mice were used in the 
present study. Strikingly, the seizure-
induced enhancement of neuronal 
Cl- extrusion capacity observed previ-
ously  in  P5-7  rats  and  now  also  in  P6  
WT (BDNF+/+) mice, was strongly im-
paired in P6 BDNF-/- mice. Accordingly, 
compared to the WT littermates, signifi-
cantly less KCC2 was incorporated into 
the plasma membrane in BDNF-/- pups 
following kainate-induced status. 
Identical levels of total hippocam-
pal KCC2 protein and of Cl- extrusion 
capacity of CA1 pyramidal neurons were 
observed in BDNF-/- and  WT  mice at 
P13-14. This provides strong support for 
the conclusion that the observed impair-
ment in functional activation of KCC2 is 
not  a  result  of  a  general  impairment  in  
the developmental up-regulation of 
KCC2 as a result of lack of BDNF.  
In order to investigate the time 
course of the functional enhancement of 
KCC2 following neonatal seizures, the 
window for assessment of KCC2 func-
tion was extended from the 1 hour after 
slicing recovery up to 5 hours. Interest-
ingly, in WT P6 mice, a progressive 
decay  in  the  efficacy  of  Cl- extrusion 
was observed after the initial up-
regulation. The total level of KCC2 
protein in hippocampal slices prepared 
from kainate-injected animals was sig-
nificantly decreased by the 4th hour 
following recovery from slicing. Both 
the down-regulation of KCC2 function 
and total protein could be prevented by 
incubating the slices with MDL-28170, 
an  inhibitor  of  the  Ca2+-activated prote-
ase calpain. 
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 ACTIVITY-DEPENDENT 5.3
CLEAVAGE OF KCC2 
MEDIATED BY CALCIUM-
ACTIVATED PROTEASE 
CALPAIN (III) 
The main finding of this study was that 
KCC2 is subject to calpain-mediated 
cleavage following intense NMDAR 
activation. Treatment of slices with a 
Ca2+-ionophore (ionomycin), NMDA, or 
0-Mg2+ conditions, resulted in a robust 
calpain inhibitor-sensitive loss of full-
length KCC2 protein, as seen by im-
munoblotting with a polyclonal antibody 
raised against aa residues 929-1045 of 
the KCC2 C-terminal domain. An anti-
body raised against 1-100 aa of KCC2 
showed a truncated N-terminal fragment 
of KCC2, with a molecular weight ~100 
kDa, following in vitro cleavage with 
recombinant calpain. Importantly, the 
proteasome inhibitor lactacystin had no 
influence on loss of KCC2 protein trig-
gered by NMDAR activation. Interictal-
like activity induced by Mg2+ withdrawal 
led to a significant reduction in surface-
expressed KCC2, and to complete inac-
tivation of KCC2-mediated Cl- extrusion 
that could be prevented by inhibiting 
calpain activity.  
Another important finding of this 
study was that both KCC2 total protein 
and Cl- extrusion function remain stable 
for several hours in the absence of 
mRNA translation induced with emetine 
or cycloheximide. Accordingly, no rapid 
change in total KCC2 protein was ob-
served in the presence of the broad-
spectrum protease inhibitor leupeptin. 
Together these observations suggest the 
turn-over of total cellular KCC2 protein 
under control conditions is low due to a 
slow basal degradation rate, which is in 
direct contrast to what was suggested 
previously (cf. Rivera et al., 2004). 
Notably, robust down-regulation of 
KCC2 protein could be still induced by 
NMDAR stimulation under full block of 
mRNA translation by cycloheximide.  
In summary, the obtained data 
suggest that rapid down-regulation of 
KCC2 function is unlikely to result from 
diminished de novo synthesis of KCC2. 
It also appears that rapid down-
regulation and functional inactivation of 
KCC2 under conditions of elevated 
intracellular Ca2+ levels,  typical  to  a  
wide range of CNS insults, is a result of 
calpain-mediated cleavage. 
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 AN ION TRANSPORT-5.4
INDEPENDENT ROLE FOR 
KCC2 IN DENDRITIC 
SPINOGENESIS IN VIVO (IV) 
This study set forth to investigate wheth-
er expression of KCC2 is sufficient for 
the induction of functional dendritic 
spines during the brain growth spurt. 
Utilizing the powerful technique of 
introducing genetic material to a subset 
of  cortical  neurons  at  a  defined  time  
period during CNS development provid-
ed by in utero electroporation (IUE), 
neuronal precursors of rat neocortical 
layer 2/3 pyramidal neurons where 
electroporated  at  E17.5  with  rat  KCC2-
FL and enhanced GFP plasmids. Contra-
ry  to  a  previous  report  using  a  similar  
approach (Cancedda et al., 2007), im-
pairments in either dendritic length or 
the number of branch points were ob-
served neither at P10, P15, or P90 fol-
lowing overexpression of KCC2 using 
IUE. The only obvious methodological 
difference with regard to the above-
mentioned study is that in the present 
work, in order to ensure complete visual-
ization of dendritic arbors, all neurons 
where filled post-hoc with Lucifer-
yellow, whereas in the other study den-
dritic morphology was assessed based on 
the GFP signal alone. Overexpression of 
KCC2 was, however, associated with a 
persistently increased spine density of 
both apical and basal dendrites of layer 
2/3 pyramidal neurons at P10, P15, and 
P90. Importantly, the increased density 
was  seen  in  spines  in  a  wide-range  of  
head diameters, indicating that overex-
pression of KCC2 was associated with 
the induction of synaptically active 
spines. This notion was corroborated by 
the observation of significantly higher 
frequency of mEPSCs recorded from 
KCC2 overexpressing neurons compared 
to neighboring non-transfected control 
neurons solely expressing native KCC2.  
Based on the previous work by Li 
et al. (2007), which implicated a struc-
tural, ion transport-independent role for 
KCC2 in the maintenance of functional 
dendritic  spines,  the  ability  of  the  N-
terminally deleted KCC2-?NTD to 
induce spines was assessed. As expected 
on  the  basis  of  the  results  by  Li  et  al.  
(2007) this KCC2 variant, which is 
devoid  of  Cl- extrusion function was 
observed to induce a comparable level of 
spines as the full-length KCC2-FL. 
Unexpectedly, the mere C-terminal 
domain of KCC2 (KCC2-CTD) was able 
to induce spines with wide range in 
diameter,  similarly to the KCC2-FL and 
the KCC2-?NTD.  
To shed further light on the under-
lying mechanism of KCC2-mediated 
spinogenesis,  effects  of  the  KCC2  mu-
tant KCC2-C568A, which is devoid not 
only of the ion transport function but 
also of the interaction with the actin 
cytoskeleton via protein 4.1N (cf. Horn 
et al., 2010), were assessed. Importantly, 
overexpression of this KCC2 mutant had 
no effect on spine density or spine head 
diameter. Together with data obtained 
using KCC2-?NTD and KCC2-CTD, 
this result suggests that KCC2-induces 
spines via an ion transport-independent 
function mediated by its C-terminal 
domain that most likely involves an 
interaction with the cytoskeleton via 
4.1N.  
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6 DISCUSSION 
 STUDY I 6.1
The main finding of the present study is 
that a single neonatal seizure episode 
triggers a fast increase in neuronal Cl- 
extrusion capacity which leads to a large 
hyperpolarizing shift in EGABA-A and  to  
the development of a native somato-
dendritic EGABA-A gradient in rat hippo-
campal CA1 pyramidal neurons at P5-7. 
The post-seizure value of EGABA-A is 
close to that seen in mature neurons. 
Notably, an approximately 2-fold activi-
ty-dependent increase in the plasma-
lemmal protein pool with no change in 
total KCC2 protein was observed by two 
different biochemical approaches, bioti-
nylation and cleavage of surface pro-
teins. The increase in surface KCC2 may 
not fully account for the increase in Cl- 
extrusion efficacy since additional 
changes in the intrinsic turnover rate of 
the transporter may take place in paral-
lel, but it is likely to play a role in the 
functional effects observed in the present 
studies. That fast changes in membrane 
trafficking of KCC2 have a significant 
effect on K-Cl cotransport obtained 
further support from the result that inhib-
iting endocytosis in single pyramidal 
neurons by adding the endocytosis 
blocker DIP into the patch pipette led to 
an increase in the Cl- extrusion capacity. 
These results are striking as they demon-
strate that the efficacy of neuronal Cl- 
extrusion by KCC2 is not rate-limited by 
the total expression level of the trans-
porter protein at this early developmental 
stage; and that KCC2 functionality can 
be precociously enhanced in an activity-
dependent manner close to the level that 
is seen after the developmental shift in 
EGABA-A. 
To the best of my knowledge, no 
prior study has investigated the immedi-
ate consequence of a single neonatal 
seizure episode on the capacity of hippo-
campal pyramidal neurons to extrude 
Cl-. The work by Nardou et al. (2011b) 
using two isolated interconnected hippo-
campi demonstrated that following 15 
three minute-long kainate (400 nM) 
applications at 20 minute intervals to one 
of the hippocampi led to emergence of 
spontaneous ictal events in the drug-
naive contralateral hippocampus and loss 
of Cl- extrusion capacity paralleled by 
internalization of KCC2 in CA3 pyrami-
dal neurons. In the present work a single 
application of kainate (300 nM for 10 
minutes) to hippocampal slices from 
neonatal rats of comparable age led to 
enhanced surface expression of KCC2 in 
the  CA1  region  and  an  up-regulation  of  
the neuronal Cl- extrusion capacity 
within minutes after the ictal event. An 
identical up-regulation of KCC2 was 
observed in vivo following a single 
kainate-induced SE. Thus, it appears that 
the initial response to a neonatal ictal 
event is enhancement of KCC2 surface 
expression and consequent neuronal Cl- 
extrusion capacity. However, aggrava-
tion of seizures leads to down-regulation 
of KCC2. An interesting hypothesis for 
future work is that the initial functional 
enhancement of KCC2 acts as an intrin-
sic anti-ictogenic or an antiepileptogenic 
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mechanism in the neonatal hippocampus. 
The gradual increase in KCC2 expres-
sion during neuronal maturation has 
often been considered as an explanation 
of the parallel developmental shift in 
EGABA-A (Ben-Ari  et  al.,  2007).  An  im-
portant conclusion from the present work 
is that immature hippocampal neurons 
are capable of undergoing a large preco-
cious negative shift in EGABA-A, based on 
a more efficacious utilization of their 
low total KCC2 protein pool. However, 
fast post-translational effects such as 
those described in the present work 
obviously do not exclude long-term 
effects based on enhanced KCC2 protein 
synthesis. Indeed, the work by Galanop-
oulou (2008) on a similar neonatal sei-
zure model, but involving three episodes 
of SE each with one day interval, 
demonstrated that an increase in KCC2 
expression leads to sustained KCC2 
activation, which apparently takes place 
after the initial post-translational effect 
described in the present work. In future 
work it would be of interest to determine 
whether such long-term changes in 
KCC2 protein expression take place 
already after a single episode of neonatal 
SE, after the time window of the present 
experiments. 
In view of the tight functional and 
structural coupling of KCC2 and the ?2 
subunit of the Na-K ATPase (cf. Ikeda et 
al., 2004), it is interesting that the up-
regulation of the membrane expression 
of KCC2 was paralleled by a quantita-
tively similar up-regulation of the Na-K 
ATPase, the ion pump which ultimately 
provides the thermodynamic driving 
force for K-Cl cotransport mediated by 
both KCC2a and KCC2b. It would be 
interesting to investigate whether KCC2 
physically interacts with the Na-K 
ATPase  also  through  the  ?3  subunit,  as  
the  expression  of  this  subunit  of  the  
Na-K ATPase appears to be neuron-
specific while that of ?2 is observed in 
both glia and neurons (Cameron et al., 
1994). While the available data indicate 
that the KCC2b isoform is required for 
the developmental shift in EGABA-A (see 
section 2.3.1) little is known about the 
functional significance of KCC2a (Uva-
rov et al., 2007; 2009). Nevertheless, the 
parallel activity-dependent up-regulation 
of the two isoforms is of interest because 
of their capability of heterodimerization 
(Uvarov et al., 2009). Recent work 
suggests that heterodimerization of 
KCC2 with other KCCs might be a way 
of regulating KCC2 trafficking and 
function  (Ding  et  al.,  2013;  see  also  
Wenz et al., 2009). 
The similarities of the fast increase 
in  the  Cl- extrusion capacity paralleled 
by the increase in the surface expression 
of KCC2 observed between the in vivo 
and in vitro models in the present study 
are consistent with the idea that the two 
neonatal seizure models have common 
underlying molecular mechanisms of 
KCC2 regulation in response to epilepti-
form activity. The block of the activity-
induced activation of KCC2 by K252a in 
the in vitro model is interesting in light 
of the previous finding that K252a 
blocks the activity-induced down-
regulation of KCC2 in mature neurons 
(Rivera et al., 2004). A similar age-
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dependent difference in the direction of 
the effect induced by a signaling cascade 
has been described for the action of 
BDNF  on  GABAA currents, which are 
enhanced by BDNF in immature and 
suppressed in mature neurons 
(Mizoguchi et al., 2003). Based on the 
K252a effect in vitro, BDNF-TrkB 
signaling is a promising candidate medi-
ating the activation of KCC2 in vivo.  
 
 STUDY II 6.2
This study not only mechanistically 
elaborates on the findings of Study I, but 
demonstrates that the developmental up-
regulation of KCC2 can take place in the 
absence of BDNF. The results obtained 
using  full  homozygous  BDNF  KO  mice  
demonstrated that the fast functional up-
regulation of KCC2 following a single 
neonatal seizure is dependent on BDNF 
signaling. In Study I, enhanced surface 
expression of KCC2 was observed in 
parallel with functional enhancement of 
the Cl- extrusion capacity. Similarly, in 
this Study BDNF KO mice exhibited 
reduced levels of KCC2 compared to 
WT littermates, suggesting that disrupted 
KCC2 trafficking in BDNF KO mice 
may account for the lack of enhancement 
of Cl- extrusion following neonatal 
seizures. Interestingly, work on traffick-
ing  of  GABAARs has identified BDNF-
TrkB signaling as an important regulato-
ry (Brunig et al., 2001). Given that the 
seizure-induced up-regulation of both 
KCC2 function and surface expression 
were completely prevented by the Trk 
inhibitor K252a (Study I), and in the 
BDNF KO mice, it appears that this 
signaling pathway may be important also 
for regulation of KCC2 trafficking.  
Impairments in the developmental 
up-regulation of functional KCC2 pro-
tein, which have been  
suggested to accompany changes in 
BDNF-TrkB signaling (Aguado et al., 
2003; Carmona et al., 2006; Ludwig et 
al., 2011b), are an unlikely reason for the 
observed impairment activation of 
KCC2 following neonatal seizures, 
because KCC2 total protein levels were 
indistinguishable between BDNF KO 
and WT littermates at P14. Endogenous 
BDNF has been demonstrated to mediate 
fast activity-dependent down-regulation 
of KCC2 in older animals (Rivera et al., 
2002; Rivera et al., 2004). Thus, it ap-
pears that activation of the BDNF-TrkB 
pathway may have opposite effects on 
KCC2 function depending on the stage 
of brain development. Intriguingly, 
recent work has demonstrated qualita-
tively different responsiveness of mouse 
brain TrkB receptors to BDNF before 
and after ~P12 (Knüsel et al., 1994; Di 
Lieto et al., 2012).  
An interesting observation made in 
Study  II  is,  that  following  a  single  neo-
natal seizure, down-regulation of KCC2 
ensues after the initial functional up-
regulation. In Study I, where changes in 
KCC2 induced by the neonatal seizure 
where examined during the early period, 
no change in the total KCC2 protein pool 
was observed. However, extending the 
experimental time window to 4 hours 
revealed progressive down-regulation of 
Cl- extrusion capacity that was paralleled 
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by significant calpain-dependent reduc-
tion of the total KCC2 protein pool. It 
was not investigated whether the pres-
ently observed down-regulation of 
KCC2 protein and transport capacity is 
mediated by TrkB. Given the sensitivity 
of KCC2 down-regulation to inhibition 
of  BDNF-TrkB  signaling  (Rivera  et  al.,  
2002; Rivera et al., 2004) and activation 
of  calpain  by  BDNF  (Zadran  et  al.,  
2010a; Zadran et al., 2010b), an interest-
ing hypothesis for future work is that the 
down-regulation of KCC2 observed 
herein is mediated by TrkB. 
 
 STUDY III 6.3
The key finding of this study is that 
KCC2, a protein instrumental in the 
development  and  plasticity  of  GABA-
ergic hyperpolarizing inhibition and in 
the maturation and function of dendritic 
spines and glutamatergic synapses, is a 
substrate of the Ca2+-activated protease 
calpain and is down-regulated following 
calpain activation. The validity of the 
present findings was extended by a 
parallel study (Zhou et al., 2012) carried 
out independently of this Thesis. This 
work, consistently the present one, 
demonstrated that down-regulation of 
KCC2 following pathological activation 
of NMDARs is attributable to calpain 
activation but not to decreased KCC2 
mRNA levels in spinal cord neurons of 
adult rats (Zhou et al., 2012).  
Calpains  constitute  a  family  of  in-
tracellular non-lysosomal cysteine prote-
ases that are activated by Ca2+ in the cell 
cytosol at neutral or slightly alkaline pH 
(Zhao et al., 1998; Goll et al., 2003). In 
contrast to relatively promiscuous deg-
radative proteases, such as many of the 
lysosomal proteases (Cuervo and Dice, 
1998), calpains regulate cellular process-
es by partially truncating a restricted set 
of substrates, conferring them post-
translational protein modifications, 
which  can  also  serve  as  signals  for  pro-
tein degradation (Wu and Lynch, 2006; 
Croall and Ersfeld, 2007; Zadran et al., 
2010a). There are so far 14 known 
members in the calpain family of prote-
ases,  out  of  which  two  isoforms,  cal-
pain-1 and calpain-2, are particularly 
abundant in the CNS (Croall and Ersfeld, 
2007).  These  two  CNS  isoforms  of  
calpain do not differ with respect to their 
substrate preference but rather in their 
sensitivity to the level of [Ca2+]i. While 
calpain-1, also known as µ-calpain is 
activated in the low µM range of [Ca2+]i, 
calpain-2 is activated only at high >0.4 
mM [Ca2+]i thereby earning its epony-
mous alias, m-calpain (Baudry et al., 
2013). The other main difference be-
tween the two major CNS calpain 
isoforms is that calpain-2 can bypass the 
Ca2+ requirement and be activated by 
BDNF-signaling via phosphorylation by 
the  MAPK/ERK  kinase  (Zadran  et  al.,  
2010a; Zadran et al., 2010b). In practice, 
it is however very difficult to specifical-
ly attribute a given effect to either of the 
two isoforms as known calpain inhibitors 
target both calpain-1 and 2 with a similar 
potency (Goll et al., 2002; Baudry et al., 
2013). The use of RNA interference to 
specifically suppress one or the other 
calpain isoform is not feasible in acute 
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preparations, such as the brain slice, as 
both of these calpain isoforms have a 
half-life of several days (Zhang et al., 
1996).  In  the  present  work,  direct  cal-
pain-mediated cleavage of KCC2 was 
demonstrated using recombinant calpain-
2. However, given the above considera-
tions, both isoforms may well be respon-
sible for the observed KCC2 down-
regulation under the present conditions 
(see also Zhou et al., 2012). Thus, here 
they are collectively referred to 
as ‘calpain’. 
Constitutive calpain cleavage of 
synaptic proteins is part of normal CNS 
function (Amini et al., 2013), and activa-
tion of calpain by excitatory amino acid 
signaling confers selective activity-
dependent cleavage of its substrates (Wu 
and Lynch, 2006; Liu et al., 2008; 
Baudry et al., 2013). Thus, the role of 
calpain-mediated signaling is pivotal in 
regulation of neuronal plasticity. Hyper-
activation of calpain under pathophysio-
logical conditions, including experi-
mental  seizures  (Bi  et  al.,  1996;  Sierra-
Paredes et al., 1999; Fujikawa, 2005; 
Sharma et al., 2009), is, however, often 
associated with neurotoxicity (Liu et al., 
2008). Increased calpain expression has 
been reported in hippocampal and corti-
cal tissue of patients with drug-resistant 
TLE (Feng et al., 2011; Das et al., 2012). 
Several studies have shown neuroprotec-
tive effects of calpain inhibitors in vari-
ous models of CNS pathology (Markgraf 
et al., 1998; Zhang et al., 2003; 
O'Hanlon et al., 2003; Yu et al., 2008; 
Nimmrich  et  al.,  2008;  Granic  et  al.,  
2010), indicating that calpain-mediated 
cleavage of proteins can be detrimental. 
In  line  with  this,  one  of  the  calpain  
inhibitors used in the present work, 
MDL 28170, has been reported to reduce 
pyramidal  cell  death  in  the  CA1  of  the  
hippocampus in a rodent model of TLE 
(Araujo  et  al.,  2008).  Thus,  the  novel  
interaction between KCC2 and calpain, 
first reported herein, may be of clinical 
interest. 
The present data acquired using 
cycloheximide, emetine, and leupeptin 
all point to a rather low basal turnover of 
KCC2.  It  should  be  noted  here  that,  
because of the several days long half-life 
of  calpain  (Zhang  et  al.,  1996),  it  is  
unlikely that the observed stability of 
KCC2 under arrested de novo translation 
is due to reduced calpain levels in the 
present experimental time window of 
four to five hours. However, previous 
data obtained with leupeptin in neuronal 
cultures (Lee et al., 2010) and analysis of 
the KCC2 surface pool in hippocampal 
slices (Rivera et al., 2004) indicated a 
high turnover rate. The data of the pre-
sent work demonstrate that activation of 
calpain can lead to fast changes in KCC2 
protein levels. While the study by Rivera 
et al. (2004) reported a constant decrease 
(0.2%/min) in the total KCC2 protein 
pool under control conditions (i.e., in 
standard physiological solution) in bio-
chemical experiments, the KCC2 protein 
level in the present study remained 
stable for at least 5 hours after recovery 
under  control  conditions  as  well  in  the  
absence of protein synthesis. The differ-
ence between previous and present data 
is most likely attributable to non-optimal 
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slice preparation and maintenance condi-
tions used in the biochemical assays by 
Rivera et al. (2004) which affected 
[Ca2+]i levels and, consequently, calpain 
activity (see also discussion section in 
the original publication, Study III). 
While the methodological approach used 
by Rivera et al. (2004) did not permit 
analysis of protein turnover per se, and 
the data demonstrated a high degradation 
rate of KCC2 under the conditions used 
for the biochemical experiments, this 
paper is often referred to (e.g. Uvarov et 
al., 2006; Yang et al., 2010) as evidence 
for fast down-regulation of KCC2 to 
take place at the transcriptional level. 
The  present  work  shows  that  such  con-
clusions are unwarranted. Indeed, recent 
work by Pan and colleagues demonstrat-
ed that the chronic down-regulation of 
KCC2 protein triggered by enhanced 
NMDAR activation was not associated 
with changes at the level of KCC2 
mRNA (Zhou et al., 2012). 
In view of the low turnover rate of 
the total KCC2 protein observed present-
ly, studies reporting fast functional 
changes in the efficacy of KCC2-
mediated Cl- extrusion caused by chang-
es in gene expression warrant re-
interpretation. For example, Yang et al. 
(2010) reported that changes in EGABA-A 
taking place within 30 minutes of high 
frequency stimulation of rat CA1 pyram-
idal neurons may be blocked by employ-
ing KCC2 antisense oligonucleotides 
through the recording pipette. Surpris-
ingly, however, the authors failed to 
replicate the antisense effects using a 
high 100 µM concentration of bume-
tanide (Yang et al., 2010), which is 
known to block K-Cl cotransport (Payne, 
1997; Delpire et al., 2009; Nardou et al., 
2011b).  
The present data clearly show that 
an enhanced degradation rate of KCC2 is 
required to rapidly reduce KCC2 protein 
levels. The calpain-mediated cleavage of 
KCC2 presented here might be one of 
the major mechanisms responsible for an 
enhanced degradation of KCC2, while 
changes at the transcriptional level (e.g., 
Rivera  et  al.,  2002;  Huberfeld  et  al.,  
2007) are involved in long-term effects. 
Work by Rivera et al. (1999) demon-
strated that the KCC2 antisense approach 
to block KCC2 synthesis results in se-
verely decreased total levels of KCC2 
protein in organotypic hippocampal 
cultures after 8 hours of antisense appli-
cation. In view of the present data, this 
suggests that down-regulation of KCC2 
attributable to synthesis deficits takes 
place roughly 5-8 hours after arrest of 
KCC2 translation. It would be interest-
ing to further investigate, whether 
changes in the phosphorylation state of 
KCC2, which also are known to trigger 
enhanced degradation of KCC2 (Lee et 
al., 2010; 2011; Kahle et al., 2013), are 
involved in the regulation of calpain-
mediated KCC2 cleavage.  
Several key proteins for GABAer-
gic and glycinergic signaling, such as the 
GABA transporter GAT1 (Baliova et al., 
2009), vesicular inhibitory amino acid 
transporter VIAAT (Gomes et al., 2011), 
GABA synthesizing enzyme GAD65 
(Buddhala et al., 2012) glycine trans-
porters GlyT1 and GlyT2 (Baliova et al., 
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2004; Baliova and Jursky, 2005) are all 
cleaved by calpain. Thus, the present 
finding of calpain-mediated KCC2 
down-regulation suggests a more general 
role for calpain in the regulation of 
GABAergic and glycinergic neurotrans-
mission. This idea gains further support 
from the finding that gephyrin, a key 
protein for clustering of both GABAARs 
and GlyRs, is also a calpain substrate 
(Tyagarajan et al., 2011; Tyagarajan et 
al., 2013). An important hypothesis for 
future  work  is  that  calpain  plays  a  de-
termining role in the erosion of inhibi-
tion (cf. Trevelyan et al., 2007) that 
takes place in response to ictal activity 
and contributes to AED resistance. 
As mentioned above, in addition to 
activity-induced elevation in intracellular 
Ca2+, calpain-2 is also activated by 
BDNF signaling (Zadran et al., 2010b). 
Seizure-induced up-regulation of BDNF-
TrkB signaling (Rivera et al., 2002), 
activity-dependent endogenous release 
(Rivera et al., 2004) as well as exoge-
nous application of BDNF (Rivera et al., 
2002; Wake et al., 2007) have been 
demonstrated to result in rapid impair-
ment of KCC2 expression and function, 
demonstrating a critical role for BDNF-
TrkB signaling in down-regulation of 
KCC2. Thus, it would be of interest to 
test whether the BDNF-triggered activa-
tion of calpain plays a role in the BDNF-
induced down-regulation of KCC2.  
In conclusion, this work shows that 
fast, activity-dependent down-regulation 
of KCC2 is attributable to calpain-
mediated cleavage of the protein, and not 
to suppression of KCC2 gene expres-
sion. It thereby identifies a new molecu-
lar mechanism for the fast regulation of 
KCC2 involved in synaptic plasticity 
under physiological and pathophysiolog-
ical conditions.  
 
 STUDY IV 6.4
The main finding of this study was that 
overexpression of KCC2 induces the 
formation of functional dendritic spines. 
In humans, the most intensive period for 
synaptogenesis takes place between the 
third trimester of pregnancy and the first 
few postnatal years (Huttenlocher and 
Dabholkar, 1997; Petanjek et al., 2011). 
In rodents, the peak period of synapto-
genesis is limited to a time window 
between the second and fourth postnatal 
week (Juraska, 1982; Micheva and 
Beaulieu, 1996; De Felipe et al., 1997). 
The intimate temporal correlation be-
tween the developmental up-regulation 
of KCC2 expression and synaptogenesis 
in rodents and humans (see section 
2.3.2) points to a possible role for KCC2 
in synapse formation. The major novel 
finding of the present study is that over-
expression of KCC2 leads to increased 
dendritic spinogenesis under in vivo 
conditions. Previous work on cultured 
neurons has shown that maturation of 
dendritic spines fails when neurons are 
deprived of KCC2 expression before or 
at  the  onset  of  spinogenesis  (Li  et  al.,  
2007; Gauvain et al., 2011) and that 
overexpression of KCC2 is able to res-
cue spine development when neurons are 
transfected with KCC2 before the onset 
of  spine  formation  (Li  et  al.,  2007;  see  
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also Sun et al., 2013). Notably, in cul-
tured neurons expression of endogenous 
KCC2 is observed already before for-
mation  of  synapses  (see  Ludwig  et  al.,  
2003).  
In the present study, a striking in-
crease in the density of spines over a 
wide range of head diameters, which was 
paralleled by increased frequency of 
mEPSCs, was observed throughout the 
observed first three postnatal months in 
the rat somatosensory cortex following 
in utero electroporation of neurons at 
E17.5.  In  view  of  the  minor  effect  of  
suppression of KCC2 expression starting 
after the  onset  of  synaptogenesis  on  the  
density and morphology of spines in 
cultured hippocampal neurons and 
Purkinje cells in vivo (Gauvain  et  al.,  
2011; Seja et al., 2012), the present data 
suggest that KCC2 may play a role in the 
induction of synaptogenesis. Testing 
whether suppression of KCC2 expres-
sion after the peak period of spinogene-
sis affects the maintenance of spines, is, 
however, needed to further assess the 
differential role of KCC2 in induction 
versus maintenance of dendritic spines in 
neocortical pyramidal neurons.  
Notably, the present study did not 
demonstrate any effect of premature 
expression  of  KCC2  or  the  of  IUE  pro-
cedure per se on the dendritic length or 
branching of cortical layer 2/3 pyramidal 
neurons. This is in striking contrast with 
a previous report (Cancedda et al., 
2007), which suggested that precocious 
termination of depolarizing GABAergic 
signaling through overexpression of 
KCC2 impairs the morphological matu-
ration of layer 2/3 pyramidal neurons. 
Our data is,  however,  in agreement with 
the study by Pfeffer et al. (2009) who 
observed no morphological alterations in 
hippocampal neurons from NKCC1-/- 
mice which displayed normal dendritic 
length, branching, and spine synapse 
density despite a much reduced depolar-
izing action mediated by GABAARs.  
The present work also demonstrates that 
not only is the ion transport function of 
KCC2 not needed for spine induction but 
there is apparently no necessity for 
membrane association of KCC2, as 
similar spine-induction as with KCC2-
FL was observed with KCC2-CTD, 
which is predicted (cf. Payne et al., 
1996) to contain no membrane spanning 
sequences. Unlike in the present in vivo 
experiments, work in vitro has reported 
that when expressed before the onset of 
glutamatergic synaptogenesis, KCC2-
CTD exerts dominant-negative effects 
on spine maturation (Li et al., 2007), but 
not when expressed at later time points 
(Gauvain et al., 2011). Similarly, no 
dominant-negative effects of the KCC2 
mutant KCC2-C568A (cf. Pellegrino et 
al., 2010) were observed presently on 
spine density or spine head distribution 
of layer 2/3 pyramidal neurons.  
A recent  study  reported  of  the  ex-
istence of several previously unrecog-
nized alternative KCC2 transcripts in 
both human adult and fetal brain, includ-
ing truncated KCC2 variants (Tao et  al.,  
2012). Interesting questions for future 
work are whether there are alternative 
KCC2 proteins that endogenously disso-
ciate between ion transport and spine 
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formation and whether truncated KCC2 
or  KCC2 proper  (see  also  Adusei  et  al.,  
2010; Hyde et al., 2011; Tao et al., 2012) 
contribute to disease states, such as 
schizophrenia (Glausier and Lewis, 
2012), autism spectrum disorders, fragile 
X (De Rubeis et al., 2012), and epilepsy 
(Wong and Guo, 2012), in which patho-
logical changes in dendritic spines have 
been implicated.  
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7 CONCLUSIONS  
 
The main findings of Study I are that (i) the immediate postictal effect of a neonatal 
seizure on KCC2 in the hippocampi of P5-7 rats is a robust post-translational activation 
of the transporter function of KCC2 close to the mature level of Cl- extrusion, and (ii) 
the low total level of KCC2 protein in the P5-7 hippocampus is not a limiting factor for 
functional up-regulation of KCC2 during this stage in development. Functional up-
regulation of KCC2 in response to seizures enhances the ability of neurons to cope with 
the increased intracellular Cl- loads associated with seizure activity and may represent 
an endogenous first-in-line anti-ictogenic mechanism of the neonate brain by keeping 
the  reversal  potential  of  GABAAR-mediated responses more negative than the action 
potential firing threshold.  
 
The results of Study II expand on the mechanism of the functional activation of KCC2 
as an immediate response to a neonatal seizure. The results obtained in this study using 
mice  with  full  genetic  disruption  of  BDNF  expression,  together  with  the  data  on  the  
effects of Trk receptor kinase inhibition in Study I, strongly indicate that intact BDNF-
TrkB signaling is necessary for the precocious functional up-regulation of KCC2 to take 
place in response to neonatal seizure. Study II also reports that BDNF-signaling is not a 
requirement for the canonical up-regulation of KCC2 during development. Together, 
these findings highlight the importance of BDNF-signaling in fast post-translational 
regulation of KCC2.  
 
The results of Study III indicate that down-regulation of KCC2 total protein and neu-
ronal Cl- extrusion capacity is unlikely to be attributed to a deficit in synthesis of KCC2 
protein, and demonstrate that under conditions of elevated [Ca2+]i the enhanced degra-
dation and functional inactivation of KCC2 is a consequence of KCC2 cleavage by the 
Ca2+-activated protease calpain.  
 
Study IV reports an ion transport-independent role for KCC2 in the genesis of dendritic 
spines in vivo, and demonstrates that expression of KCC2 is sufficient for the induction 
of functional glutamatergic spines during the brain growth spurt. 
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